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organism. This homeostatic balance is tightly regulated by a variety of sophisticated processes that occur
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determine if this change alters disease progression. In chapter 3, I study the role of neuropeptides in regulating
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critical aspect of metabolic homeostasis.
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ABSTRACT 
 
GENETIC REGULATORS OF TOXICITY IN A MOUSE MODEL OF AMYOTROPHIC  
 
LATERAL SCLEROSIS AND A WORM MODEL OF ANOXIC INJURY 
 
Shachee Doshi 
Robert G. Kalb 
 
The equilibrium between energy consumption and energy production defines the 
metabolic rate of an organism. This homeostatic balance is tightly regulated by a variety 
of sophisticated processes that occur within and between cells and tissues. These 
processes also allow animals to tolerate some deviation from baseline by recruiting 
adaptive mechanisms to bring cells and organisms back to homeostasis. Temporary 
changes in the organism’s environment, such as alterations in ambient temperature, 
oxygen levels and infections are examples of conditions where animals must have a 
healthful adaptive metabolic response, allowing them to sustain the duration of the 
stress. However, in conditions of chronic disease or long-term stress, these adaptive 
mechanisms can no longer be protective and may even contribute to the damage 
incurred by the animal. Therefore, metabolism can either be healthful and adaptive to 
stressors, or stressors can induce pathogenic metabolic changes in an organism. In this 
body of work, I explore this bidirectional relationship between external stresses and 
organismal metabolism. In chapter 2, I investigate the contribution of hypermetabolism 
(energy production > energy consumption) in a mouse model of the disease amyotrophic 
lateral sclerosis (ALS). While hypermetabolism is a feature of ALS, it is not known if it 
contributes to disease pathogenesis. In a mouse model of ALS, I genetically induce 
hypometabolism to determine if this change alters disease progression. In chapter 3, I 
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study the role of neuropeptides in regulating hypometabolic tolerance to extreme oxygen 
deprivation. Here, I employ C. elegans, a genetically tractable soil-dwelling nematode, 
as a model. Worms can tolerate long durations of anoxia by lowering their metabolic 
rate, and loss of neuropeptide signaling can further increase its ability to tolerate this 
stress. I investigate various aspects of neuropeptide regulation of this phenotype. 
Together, these projects demonstrate the role of metabolism in health, disease and 
stress, and suggest that inter-cellular and inter-tissue communication is a critical aspect 
of metabolic homeostasis. 
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CHAPTER 1  
 
 
General Introduction 
 
Metabolic homeostasis is essential to health and physiology. It operates at 
cellular and organismal levels to coordinate and balance energy intake and expenditure. 
However, it can deviate from this homeostatic balance in conditions of stress and 
disease. Here, I will explore two different contexts of metabolism - one in which 
metabolic adaptation is detrimental to a particular neurodegenerative disease, and 
another in which metabolic adaptation is essential to survival against an environmental 
stress. 
 
Metabolic dysfunction at the organism level is a feature of many 
neurodegenerative diseases such as Alzheimer’s disease (AD), Amyotrophic lateral 
sclerosis (ALS), Huntington’s disease (HD) and Parkinson’s disease (PD) (Dupuis et al., 
2011; Cai et al., 2012). These changes are not  identical across these diseases, but it is 
interesting to note that many of the same markers such as circulating hormones and 
body weight are commonly altered in all of them. A brief outline of these abnormalities 
follows below. 
In Alzheimer’s disease, the most widely occurring neurodegenerative disease 
and the leading cause of dementia and cognitive impairment, increased body weight in 
midlife (35-65 years) has a significant correlation with onset of dementia in later life 
(Albanese et al., 2017). Type 2 diabetes is strongly correlated with AD, brain glucose 
metabolism is decreased in patients with AD compared to controls, and abnormalities in 
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glucose metabolism manifest decades before cognitive symptoms of AD (Mosconi, 
2005; Chen and Zhong, 2013; Duran-Aniotz and Hetz, 2016). AD patients can manifest 
neuronal insulin resistance and have increased brain insulin receptor expression (Frölich 
et al., 1998; Stanley et al., 2016). Metabolic hormones such as leptin and ghrelin are 
also altered in AD – higher circulating leptin correlates with higher brain volume and 
reduced incidence of dementia and AD while ghrelin mRNA is decreased in cortex of AD 
patients (Lieb et al., 2009; Gahete et al., 2010).  
HD patients have increased weight loss and increased fasting energy 
expenditure than controls (Pratley et al., 2000; Aziz et al., 2010). Patients also have 
increased leptin secretion with increased CAG repeat length (Ahmad Aziz et al., 2009). 
Total cholesterol, high density lipoprotein and low density lipoprotein levels are all 
decreased in HD patients compared to familial controls (Wang et al., 2014). 
In PD, patients have increased serum levels of insulin-like growth factor 1 
compared to healthy controls (Godau et al., 2010). Patients also demonstrate decreased 
body weight (Chen et al., 2003), and patients with decreased weight loss also have an 
unrelated decrease in circulating leptin (Evidente et al., 2001). 
ALS patients also present with a hypermetabolic phenotype, measured as a 
higher resting energy expenditure, that manifests early, is persistent and is correlated 
with survival (Desport et al., 2001; Bouteloup et al., 2009; Funalot et al., 2009a). A 
higher premorbid BMI and higher fat diets are associated with better disease 
progression in ALS (Ngo et al., 2014). Patients have impaired glucose tolerance (Pradat 
et al., 2010), and the level of total cholesterol is two-fold higher in ALS patients 
compared to controls (Dupuis et al., 2008). 
While there is a growing body of work highlighting a wide range of organism level 
deficits in metabolic homeostasis in neurodegenerative diseases, it is unknown if this 
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altered metabolic state contributes to worsening disease progression. It is, therefore, 
important to gain a deeper understanding of how perturbations in metabolic homeostasis 
contributes to the progression of various neurodegenerative diseases in order to devise 
effective treatment plans. In the current work, we focus on ALS to highlight and address 
whole organism metabolic changes observed in this disease.  
 
Amyotrophic Lateral Sclerosis 
 Amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, Charcot 
disease and motor neuron disease, is a devastating neurodegenerative disease 
characterized by progressive loss of upper and lower motor neurons leading to muscle 
wasting, paralysis and ultimately death due to respiratory failure. It has a worldwide 
incidence of 1.9 in every 100,000 people (Arthur et al., 2016), and affects more men 
than women. It is also more prevalent in non-Hispanic populations, and affects military 
veterans and sports people at a higher rate than the rest of the population (Hardiman et 
al., 2011; Kiernan et al., 2011). ALS is the most common adult onset motor neuron 
disease, with an average age of onset around 55-60 (Ferraiuolo et al., 2011). It 
progresses rapidly, and most patients die within 3-5 years of symptom onset. In addition 
to motor symptoms, a subpopulation of patients also manifests deficits in cognitive 
functions such as decision-making and language processing (Phukan et al., 2007). As a 
result, ALS has significant clinical and biological overlap with frontotemporal dementia, 
and the two are thought to be on a pathophysiological continuum (Ling et al., 2013). Ling 
et al carefully describe the clinical features that set up the ALS-FTD spectrum as well as 
underlying genes and molecular mechanisms that may regulate ALS-FTD. For example, 
mutations in some genes such as SOD1 and TDP-43 are thought to predominantly result 
in ALS, while others in VCP and Tau are predominant in causing FTD, and still others 
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like C9orf72 can cause either ALS or FTD or both. It is expected that the number of 
people living with ALS will increase from 222,801 in 2015 to 376,674 in 2040, 
representing an increase of 69% (Arthur et al., 2016), and the disease will thus place a 
significant economic burden on society. There is currently no cure for the disease and 
Riluzole, one of two drugs approved for treatment of ALS, provides a very modest 
improvement in patient outcome (Renton et al., 2014). The FDA approved a second 
drug, Radicava, earlier this year, 22 years after Riluzole. However, it too, was only able 
to slow symptoms in a 6-month clinical trial without significantly altering disease course 
(Hardiman and van den Berg, 2017). 
The majority of ALS cases are sporadic (sALS), with no known single genetic 
abnormality but 5-10% of cases are familial (fALS) and result from single gene mutations 
with a family history of the disease (Ferraiuolo et al., 2011). The most common genetic 
cause of fALS is C9orf72, and the pathogenic expansion of a hexanucleotide repeat in 
the gene accounts for 25-40% of familial cases (Allen et al., 2014; Tan et al., 2014). 
While the exact function of the native protein encoded by the C9orf72 locus remains 
unclear, the disease-associated allele of C9orf72 (containing the GGGGCC repeat 
expansion) disrupts many aspects of cellular function. Cells with expanded C9orf72 have 
RNA accumulations in the nucleus with improper RNA processing and mis-splicing 
(Prudencio et al., 2015) and dysfunctional trafficking between the nucleus and cytoplasm 
(Zhang et al., 2015).  
The second most common causative gene in fALS is the Cu/Zn superoxide 
dismutase 1 (SOD1), accounting for 12-20% of familial cases (Renton et al., 2014). 
SOD1 is a cytosolic enzyme and is responsible for scavenging free radicals and 
converting superoxide to hydrogen peroxide. A large number of point mutations (>100) 
in SOD1 have been associated with ALS, and these mutations cause a toxic gain of 
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function in the enzyme, which leads to pathology (Mattiazzi, 2002; Lin and Beal, 2006). 
Mutations in TAR DNA-binding protein of 43kDa molecular weight (TDP-43), fused in 
sarcoma (FUS), optineurin (OPTN), valosin-containing protein (VCP), among others, are 
also known to cause fALS (Ferraiuolo et al., 2011; Renton et al., 2014).  
Generally, patients with fALS have an earlier age of onset than those with sALS, 
however, disease progression and pathological features of sALS and fALS share 
commonalities (Kiernan et al., 2011; Ngo et al., 2014). The most widely used mouse 
models of the disease are based on fALS-linked mutations in SOD1 and TDP-43. These 
models share many of the features of the disease, including death of motor neurons, 
muscle wasting, limb paralysis and short lifespan (Picher-Martel et al., 2016). Studies in 
these models of disease have revealed many cellular features and pathogenic 
characteristics associated with disease progression. Some of these include dysregulated 
RNA metabolism/trafficking, endoplasmic reticulum (ER) stress, oxidative stress, protein 
misfolding and aggregation, autophagy, mitochondrial dysfunction, impaired axonal 
transport and inflammation (Tefera and Borges, 2017). Adding to this list is a growing 
body of work implicating the role of altered metabolism to ALS pathophysiology. 
 
Metabolic dysfunction in ALS 
 Studies in ALS patients and animal models have revealed a range of organism-
level and cellular metabolic abnormalities, some of which are highlighted below: 
(i) ALS patients and mouse models display hypermetabolism, a state in which energy 
expended by the organism is greater than the energy consumed (Dupuis et al., 2004; 
Bouteloup et al., 2009; Dupuis et al., 2011; Ngo et al., 2014). There is a 20% increase in 
resting energy expenditure measured by indirect calorimetry in a significant 
subpopulation (48%) of ALS patients, even after normalizing for fat-free mass 
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(Bouteloup et al., 2009). In a small study, 100% of patients with fALS were 
hypermetabolic, as compared to 52% of sALS patients (Funalot et al., 2009a). 
(ii) There is a strong correlation between premorbid BMI and ALS risk. Patients with low 
BMI have decreased survival compared to those with higher BMI (Jawaid et al., 2010a). 
Additionally, individuals with higher BMI (overweight or obese) earlier in life had a lower 
risk of developing ALS. There was a 21% decrease in rate of ALS with every 5-unit 
increase in BMI (O'Reilly et al., 2013).  
(iii) ALS patients display dyslipidemia, where the ratio of low density lipoproteins (LDL) to 
high density lipoproteins (HDL) is high (Dupuis et al., 2008; Jawaid et al., 2010b). 
(iv) ALS patients present with a higher prevalence of hyperglycemia and glucose 
intolerance compared to healthy controls. Additionally, ALS patients and mouse models 
have lower glucose uptake in certain regions of the brain and the spinal cord (Miyazaki 
et al., 2012; Cistaro et al., 2014). This demonstrates impaired glucose metabolism in 
patients and animal models of ALS. 
(v) ALS patients and mouse models have mitochondrial dysfunction. Motor neurons from 
patient spinal cords display morphologically abnormal mitochondria, appearing 
aggregated, swollen and vacuolated (Sasaki and Iwata, 2007). Similarly, SOD1 and 
TDP-43 mouse models of ALS are also similar in their morphology (Magrané et al., 
2014; Stribl et al., 2014). In addition, mitochondrial function is compromised in ALS as 
evidenced by decreased electron transport chain activity and decreased ATP production 
in spinal cords from patients and animal models (Mattiazzi, 2002; Wiedemann et al., 
2002; Kirkinezos et al., 2005). The work in mice shows that these mitochondrial 
abnormalities present earlier than motor symptoms, and may indicate a role for cellular 
energy dysfunction in disease pathophysiology. 
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 Together, these data indicate significant perturbations in organism-wide as well 
as cellular changes in metabolism associated with ALS. Is organismal metabolic 
dysfunction a result of underlying cellular pathology in ALS, or does it contribute to 
causing disease pathology? If the latter is true, these metabolic parameters could be 
potential therapeutic targets to alter course of disease. Data from mouse studies suggest 
that the latter may be true. For example, mitochondrial dysfunction as well as altered 
expression of lipid metabolism genes occurs at presymptomatic stages in ALS 
(Ferraiuolo et al., 2011). Certain dietary interventions, all involving different types of high 
caloric diets have benefited mutant SOD1 mice (Dupuis et al., 2004; Zhao et al., 2006; 
Ari et al., 2014). In patients, similar dietary manipulations have also proven successful, 
albeit the size of the study was small. Patients fed a high carbohydrate, high calorie diet 
had an increased lifespan with delayed weight loss and fewer adverse events compared 
with patients fed a regular diet (Wills et al., 2014a). These studies indirectly suggest that 
metabolic dysfunction, specifically hypermetabolism, could be a targeted for therapeutic 
intervention in ALS. However, the question that remains is whether directly altering 
metabolic dysfunction can be beneficial to disease progression. 
Previous studies from our lab have also tried to address hypermetabolism in 
SOD1 mice bearing the G93A point mutation by genetically inducing a lower metabolic 
state (Lim et al., 2014). This was achieved by generating G93A mutant SOD1 mice that 
had a deficiency in the leptin hormone. Leptin is a circulating hormone released by 
adipocytes. It crosses the blood brain barrier and acts on leptin receptors in the 
hypothalamus to suppress hunger and appetite. Leptin deficient animals are obese and 
hypometabolic, as they are worse at suppressing hunger and inducing satiety. In their 
study, Lim et al found that in agreement with the literature, G93A SOD1 single mutant 
mice were hypermetabolic. Leptin deficient (ob/+) single mutant mice, on the other hand, 
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were overweight and hypometabolic. G93A SOD1 and ob/+ double mutant mice mimic 
the weight gain and hypometabolic phenotype of ob/+ mice, demonstrating that 
genetically altering leptin levels is sufficient to alter the hypermetabolism of G93A SOD1 
animals. Interestingly, the double mutant mice had improved limb strength and a female 
specific increase in median lifespan compared to G93A SOD1 mice alone. This indicates 
that hypermetabolism contributes to ALS pathophysiology in the G93A SOD1 mouse 
model.  
Since leptin is a circulating hormone, it has functions in the periphery as well as 
the brain. Additionally, there is emerging evidence for non-hypothalamic actions of leptin 
in the brain (Ahima et al., 1999; Figlewicz et al., 2006; Van Doorn et al., 2017). This 
raises a few questions: 1) does leptin act on its receptor targets in the hypothalamus to 
achieve this benefit, or are its peripheral targets also important? 2) since heterozygous 
leptin deficient mice showed improvement in the G93A SOD1 background, could 
stronger hypometabolism be even more beneficial in this model? To answer these, we 
focused our studies on deletion of the melanocortin-4 receptor (MC4R), a downstream 
target of leptin in the arcuate nucleus of the hypothalamus. If leptin acts on the 
hypothalamus for its hypometabolic benefit in G93A SOD1 mice, MC4R should mimic 
leptin’s effects in the G93A SOD1 mouse, and enhance the effect because it is a 
complete null rather than a heterozygote. We hypothesized that loss of MC4R would 
induce hypometabolism and increase motor output and survival in G93A SOD1 mice. 
This work is detailed in chapter 2 of my dissertation. 
 
Metabolic adaptation to adverse environmental stresses 
 ALS serves as an example that lowering metabolic rate can be neuroprotective in 
certain neurodegenerative diseases where hypermetabolism is a feature of disease. In 
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certain acute injuries and stresses, lowering metabolic rate by therapeutic hypothermia 
is also neuroprotective. In the clinic, therapeutic hypothermia is used to treat patients 
with cardiac arrest and in newborn infants with hypoxic ischemic encephalopathy to 
prevent resultant anoxic brain damage (Nagel et al., 2014). It is also being tested as a 
therapy for other acute conditions such as traumatic brain injury and stroke (Han et al., 
2015). In therapeutic hypothermia, the core body temperature is reduced from 37°C to 
32-35°C (mild), 25-32°C (moderate) or < 25°C (severe/deep) (Lyden et al., 2006). While 
the exact mechanism for the neuroprotective effects of hypothermia remain murky, 
lowering metabolic rate in cells helps to prevent the inflammatory response and resulting 
apoptosis or necrosis in neurons.  
Despite the potential neuroprotective benefits of lowering metabolic rate in 
certain cases of disease and acute injury/trauma, humans (and many other mammals) 
do not generally alter their metabolic rate physiologically in response to disease, injury, 
or environmental stress. Many other species, however, have evolved hypometabolic 
mechanisms to adapt to environmental stresses such as extreme temperatures and low 
oxygen levels. A large number of birds and mammals hibernate to conserve energy 
during winter months. The western jumping mouse can hibernate for upto 9 months of 
the year, and edible dormice can hibernate upto 11 months in years they are non-
reproductive (Cranford, 1983; Hoelzl et al., 2015). During hibernation, animals suspend 
feeding, locomotion and reproduction. This is achieved by lowering metabolic rate 
leading to slow breathing, decreased heart rate and lower core temperature. Seasonal 
hibernation can thus help animals reduce energy expenditure by as much as 85% (Dark, 
2005). Some animals enter a state of torpor where they decrease energy utilization on 
shorter timescales – hours or days Hummingbirds can lower their core temperature and 
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metabolic rate during the night (Hargrove, 2005). Similarly, when oxygen availability is 
reduced, many animals adapt by lowering their metabolic rate. Worms, flies, zebrafish, 
turtles and even mammals, such as the naked mole-rat, are able to survive extreme 
oxygen deprivation (anoxia) by reducing metabolic demand (Ultsch and Jackson, 1982; 
Krishnan et al., 1997; Van Voorhies and Ward, 2000; Padilla and Roth, 2001; Park et al., 
2017).  
 Humans too adapt to certain environmental stresses on the evolutionary timescale. 
For example, populations of people that live in high altitude regions such as Tibet have 
differentially expressed genes in order to efficiently utilize limited oxygen in that 
environment (Simonson et al., 2010). They have a normal metabolic rate despite severe 
arterial hypoxia, potentially representing an adaptation to extreme environments over 
thousands of years. The authors found genes in the hypoxia-inducible factor signaling 
pathway such as EGLN1, EPAS1 and PPARA were positively selected in Tibetan 
highlanders. Additionally, high altitude-dwelling Tibetans with lower levels of hemoglobin 
also have increased cardiac output and greater exercise capacity (Simonson et al., 
2015).  
 These adaptive advantages are present in select human groups because they 
evolved over long timescales. Therefore, not all humans can adopt these strategies to 
survive environmental stresses on the order of days or months. Many mammals, 
however, including primates like the Madagascan lemur, can hibernate to adapt to 
environmental stressors (Dausmann et al., 2004). The western painted turtle survives 
oxygen deprivation and freezing temperatures, and has many differentially expressing 
genes in anoxia that have human orthologs such as the glucose transporter GLUT1 and 
an apolipoprotein encoding gene APOLD1, among others (Shaffer et al., 2013). Studying 
metabolic adaptations in these animals can thus be utilized to understand if similar 
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changes would benefit humans, who have similar genes and molecular pathways, when 
challenged with similar environmental stresses. Gaining a better understanding of 
adaptations to environmental stresses can also have potential benefits for acute injury-
related challenges or chronic challenges such as space travel. In fact, NASA is studying 
torpor to allow humans to survive long journeys in space (www.nasa.gov).  
 Then nematode Caenorhabditis elegans (C. elegans) is a great animal model to 
study response and adaptation to changes in environment (described in detail below). In 
chapter 3 of my dissertation, I will describe work in C. elegans to focus on severe 
oxygen deprivation (anoxia) as one such environmental stress. The goal of my project 
was to expand on previous data from our lab and specifically explain how neuropeptide 
signaling regulates the worm response to anoxia.  
 
Oxygen deprivation in C. elegans – hypoxia vs. anoxia 
 C. elegans is a 1mm long, transparent nematode that normally dwells in soil and 
rotting vegetable matter. It was established as a powerful organism by Sydney Brenner a 
few decades ago (Brenner, 1974) and has since been used to study genetics, cell 
biology, circuit function and basic behaviors. It feeds on bacteria and is easily cultivated 
in the lab on agar plates seeded with a lawn of the E. coli strain OP50, although other 
strains of feeding bacteria are used depending on the study question. There are many 
advantages to studying worms as a model organism. C. elegans has a short life cycle – 
it grows from egg to adulthood in 3 days when raised at 20°C, and lives for 2-3 weeks, 
so experiments can be done relatively rapidly. It is primarily a self-fertilizing 
hermaphrodite and each animal can lay upto 300 eggs, allowing for high throughput 
experiments. It is transparent, allowing for ease of microscopy and use of fluorescent 
genetic markers. Its anatomy is well studied – it has exactly 959 somatic cells and 302 
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neurons and its neuronal wiring diagram is known. Its genome has been sequenced and 
a large number of C. elegans genes have homology with mammals and even humans 
(www.wormbook.org). 
Since they live in the soil and rotting fruit, worms frequently encounter oxygen-
depleted microenvironments in their natural habitat and can tolerate low oxygen well. 
They generally prefer 5-12% O2 environments (Gray et al., 2004) but are able to survive 
hypoxia (<0.5 - 1% O2) without altering feeding, locomotion or reproduction (Nystul et al., 
2003; Miller and Roth, 2009). This requires the activation of the hypoxia induced 
transcription factor hif-1 and its downstream gene targets. Their response to anoxia 
(<0.1% O2), however, is markedly different and is hif-1-independent (Padilla et al., 2002; 
Ghose et al., 2013). In anoxia, animals enter a reversible state of ‘suspended animation’ 
in which they cease all movement, feeding and reproduction. Larvae and young adults 
can tolerate 24 hours of suspended animation under anoxia at 20°C, but lethality 
increases with increasing temperature and increasing duration of anoxia exposure (Scott 
et al., 2002; Mendenhall et al., 2006a). Those that survive extended anoxia have striking 
morphological defects and tissue damage (Scott et al., 2002). There are fewer neurons, 
suggesting cell death; there is a pronounced cell-swelling phenotype in the pharynx and 
across the body wall muscle, reminiscent of necrosis; there is an axonal beading 
phenotype indicating damage to neuronal integrity; nearly all myocytes display nuclear 
fragmentation.  
Besides temperature and duration of insult, other factors contributing to anoxia 
tolerance are developmental stage, diet, genotype and growth conditions (solid agar or 
liquid culture). Of the developmental stages, dauer larvae and embryos are the most 
tolerant to anoxia (Padilla et al., 2002). Exposure to anoxia for shorter durations (upto 4 
hours), also known as anoxic preconditioning, can induce changes in gene expression 
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that provide a protective advantage against long term anoxia. This can occur via 
changes in the apoptosis pathway (ced-4) (Dasgupta et al., 2007) and induction of the 
unfolded protein response pathway (Mao and Crowder, 2010). While subpopulations of 
worms can survive long-term anoxia under certain conditions, it does lead to cellular 
injury such as loss of tissue integrity, presence of large vaucoles, distortion of the 
pharynx and necrotic-like cell swelling (Mendenhall et al., 2006b; Sun et al., 2014).  
 
A note about techniques: Worm biology under anoxic conditions is a relatively young 
field of investigation, and it is essential to point out that studies do not have a consistent 
method of inducing anoxia. Some studies (including ours) take advantage of 
commercially available biobags that generate an anoxic environment in a sealed bag via 
catalytic consumption of O2 in the bag. Others use gloveboxes or chambers that are 
outfitted to carefully control O2 concentration inside them by replacing it with N2. Some 
studies are done on solid agar culture plates and others are done in liquid media. Some 
are conducted at standard laboratory 20°C and others are conducted at a range of 
different temperatures (25-28°C). Finally, some are conducted in embryos, others at 
larval stages of development and yet others in adult worms. As a result of these 
variations in different labs for studying anoxia, there are many differences in similar 
outcome measures such as percent survival. Some basic observations that have been 
repeated by different groups have been consistent across these different techniques, but 
there is not enough data to know if every observation is similarly consistent. However, it 
is important to remain mindful of these technical differences when evaluating the results 
of each study. 
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Metabolic regulation of anoxia 
 Under anoxic stress, worms enter a state of suspended animation and resume 
regular physiological activity when re-exposed to normoxic environments. Early studies 
of worms in anoxia established that their metabolic rate during anoxia falls to as low as 
5% of normoxic levels (Van Voorhies and Ward, 2000). Presumably, this low-activity, 
hypometabolic state is an adaptive mechanism to preserve precious energy stores since 
reproduction, locomotion and tissue maintenance are energetically costly. Adult worms 
will cease all movement and appear ‘stunned’ within 8 hours of anoxia onset 
(Mendenhall et al., 2006b). While there are certain mutants (daf-2, the insulin receptor 
homolog in worms) that take longer to suspend activity, no studied mutant is capable of 
avoiding it completely.  
Studies in adult worms show that under anoxia, animals switch their primary 
energy source from fat to glycogen/glucose stores. Over a 24h anoxic exposure, animals 
can lose up to 2/3rds of their carbohydrate reserve (Föll et al., 1999). In anoxia-tolerant 
mutant (daf-2) worms, there is an increase in fat and glycogen production in intestinal 
and hypodermal cells (Kimura et al., 1997). Worm homologs of the glycoytic enzyme 
glyceraldehyde-3 phosphate dehydrogenase isoforms, gpd-2 and gpd-3, are also 
involved in anoxia tolerance (Mendenhall et al., 2006b). RNAi against these genes led to 
impaired worms after anoxia. However, these results were confounded because other 
glycolytic genes did not similarly induce anoxia sensitivity. 
ATP production, as expected, is also markedly reduced during anoxia (Föll et al., 
1999; Padilla et al., 2002). AMP-kinase (AMPK) is the master cellular sensor of the 
ATP/AMP ratio. AMPK is generally activated when cellular ATP levels fall, and its activity 
leads to an increase in energy producing anabolic processes and a decrease in energy 
consuming catabolic processes. Given that ATP levels decline during anoxia, it is 
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perhaps to be expected that AMPK activation might be upregulated to allow cells to cope 
with this energy deficit appropriately. Worms lacking aak-2, the C. elegans homolog for 
the catalytic alpha subunit of AMPK, are in fact hypersensitive to oxygen deprivation 
(LaRue and Padilla, 2011). They have decreased survival and those that survive have 
defects in motility and/or tissue morphology. Additionally, in one anoxia-tolerant mutant 
(daf-2), there is a decrease in stored carbohydrate consumption compared to wild type 
worms, and this is partially dependent on AMPK. These data suggest that carbohydrate 
availability can impact worm tolerance of anoxia, and AMPK has a role to play in 
regulating its consumption. 
 
Mitochondrial changes in anoxia 
 As the primary site for aerobic ATP synthesis in the cell, it is not surprising that 
mitochondria are sensitive to changes in available oxygen. In C. elegans at the L4 stage 
of development, 24 hours anoxia induces a stress response wherein neuronal 
mitochondria undergo fission, and upon reoxygenation, they refuse and restore their 
original shape and size (Ghose et al., 2013). This study shows that, in the suspended 
animation state, worms prefer smaller, fewer mitochondria, perhaps as a mechanism for 
limiting reactive oxygen species production. Oxidative stress is, however, induced in 
anoxia, and successful recovery from anoxia requires activity of the oxidative factor 
SKN-1/Nrf to allow proper refusion.  
 In other studies conducted in adults and in liquid media, mitochondrial damage is 
observed after just 12h of extreme oxygen deprivation (<0.2% O2). They have severely 
altered morphology, compromised membrane potential as well as accumulation of 
protein aggregates (Kaufman and Crowder, 2015). Consistent with protein accumulation, 
the authors found that the mitochondrial unfolded protein response (UPRmt), was 
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induced in these animals even as early as 4h anoxia, when animals recovered 
completely. This indicated that proteostasis in the mitochondria is extremely sensitive to 
changes in ambient oxygen. When UPRmt was experimentally induced by doxycycline or 
constitutive activation of atfs-1 (the transcription factor required for UPRmt), animals were 
protected from anoxic insult as measured by healthier mitochondria, decreased protein 
accumulation in the mitochondria and improved survival. Additionally, upregulated UPRmt 
was protective both before and after the anoxic insult, suggesting a potential priming 
mechanism to protect mitochondria and improve whole animal survival from anoxic 
stress. 
 An independent study from a different group also found that atfs-1 loss of 
function mutants were sensitive to 20h anoxia in day 1 adults, and that gain of atfs-1 
function was protective as measured by improved survival and decreased axonal 
damage (Peña et al., 2016). However, inducing atfs-1 specifically in the nervous system 
was able to rescue neurons from damage but was not able to improve survival of the 
animal, suggesting either a cell non-autonomous mechanism for atfs-1 or a requirement 
of atfs-1 function in different tissues for protection of C. elegans against anoxia.  
 
Cell non-autonomous features of anoxia in C. elegans 
 Oxygen deprivation is known to cause cell death via cell autonomous and non-
autonomous pathways. Cell autonomous mechanisms lead to induction of apopotosis 
and necrosis in injured cells (Lipton, 1999). Cell non-autonomous pathways are less well 
understood, but lead to injury of secondary cells due to signals released from primary 
injured cells. Release of glutamate and potassium from neurons exposed to hypoxia 
causes cell death in surrounding neurons (Choi and Rothman, 1990; Broughton et al., 
2009). Another example is that in focal ischemic stroke, there is neuronal death in the 
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area of the brain most exposed to the hypoxic insult, but the ischemic penumbra region 
surrounding the stroke is initially viable but experiences delayed cell death presumably 
due to non cell-autonomous factors from the directly injured neurons (Lo, 2008). As 
mentioned above, necrotic-like cell death is observed in worms after an anoxic insult 
(young adult worms exposed to 21h of ≤0.3% O2 in liquid culture) (Sun et al., 2014). To 
study cell autonomous vs non-autonomous cell death in worms after anoxia, these 
authors generated transgenic worm lines that were protected from anoxic death due to a 
loss of function mutation in the gene rars-1 (discussed in detail below), with rars-1 
rescue in specific cell types – either pharyngeal myocytes or GABA-ergic neurons. In 
this manner, just these specific cells were vulnerable to oxygen deprivation while the rest 
of the cells in the organism remained protected. They found that these lines had 
necrotic-like swelling and damage in cells of the pharynx and the tail, suggesting a cell 
non-autonomous mechanism for cellular injury after anoxia. They also found that loss of 
function in daf-2, the insulin-like receptor gene in worms, rescued the pharyngeal cell-
swelling phenotype observed after anoxia, and that this required the C. elegans FOXO 
transcription factor homolog daf-16. Interestingly, daf-16 expression in the intestine was 
able to rescue survival as well as pharyngeal cell-swelling after extreme oxygen 
deprivation, further suggesting a cell-autonomous regulation of anoxia-related injury and 
response. 
 Worms have distinct sets of sensory neurons in their head to detect changes in 
ambient oxygen. Upshifts in oxygen are detected by URX, AQR and PQR neurons, while 
downshifts in oxygen are detected by the BAG neuron. Indeed, worms deficient in BAG 
neurons due to a genetic ablation are unable to sense downshifts in oxygen (Zimmer et 
al., 2009). Interestingly, loss of BAG neurons confers a survival advantage in L4-staged 
worms exposed to anoxia (Flibotte et al., 2014). These worms, similar to wild type 
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animals, enter suspended animation when exposed to anoxia, but have a much higher 
rate of survival after 24 hours of normoxic recovery compared to wild type animals. 
While 45% of wild type animals survived 48 hours of anoxia, 67% of BAG-deficient 
animals survived the same insult (Flibotte et al., 2014). A single neuron is therefore 
capable of regulating whole animal survival when exposed to anoxia, providing yet 
another example of a cell non-autonomous mechanism for regulating the response to 
anoxia. 
 
Gene regulation of anoxia tolerance 
 In order for cell non-autonomous regulation of anoxic stress to occur, molecular 
communication between cells is necessary. Neuropeptides are soluble factors widely 
used in C. elegans to communicate between cells and tissues. Our lab recently identified 
that loss of function mutations in egl-3 and unc-31 protected developing C. elegans from 
anoxia (Flibotte et al., 2014). The egl-3 gene encodes a proprotein convertase required 
for the processing and maturation of neuropeptides (Thacker and Rose, 2000; Kass et 
al., 2001), and the unc-31 gene encodes the C. elegans homolog of the calcium-
dependent activator protein for secretion (CAPS), required for the secretion of 
neuropeptide-carrying dense core vesicles (Speese et al., 2007). Hence, loss of 
neuropeptide signaling is protective against anoxic stress in developing worms. 
However, neuropeptide signaling is not necessary in BAG neurons for this protective 
phenotype. Restoring egl-3 function specifically in BAG neurons in an egl-3 null 
background does not rescue egl-3-mediated increase in anoxic survival (Flibotte et al., 
2014). It remains to be understood which cells neuropeptides might act in for this benefit, 
what mechanistic pathways neuropeptides employ to regulate the response to anoxia 
and which specific neuropeptides might be involved in extending survival under the 
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hypometabolic conditions induced by anoxia. This is the primary focus in chapter 3 of 
this dissertation. 
 Other genes known to affect C. elegans survival against anoxia are enumerated 
below. In chapter 3, we explore the contribution of some of these genes to neuropeptide-
mediated regulation of anoxia survival.  
daf-2: Loss of function mutants in daf-2, the worm homolog of the insulin-like growth 
factor 1 receptor, leads to strong anoxia resistance in worms. Mutants are able to 
survive anoxia (upto 72h) induced in different ways significantly better than wild type 
worms (Scott et al., 2002; Mendenhall et al., 2006a). This survival benefit is dependent 
on the activation of the transcription factor daf-16, the worm homolog of FOXO, 
downstream of daf-2. Further, daf-2 expression in muscle and neurons, but not intestine, 
is necessary for this effect. These data implicate the insulin signaling pathway in 
regulating worm response to anoxia. 
rars-1: Loss of function mutations in rars-1, the worm homolog of the arginyl aminoacyl 
t-RNA synthetase (AAR), significantly protects worms from anoxia-induced death 
(Anderson et al., 2009). This effect was partially due to induction of the unfolded protein 
response. Interestingly, RNAi against almost all other AARs in C. elegans also protected 
them from anoxia, suggesting that translational repression plays a critical role in 
surviving this stress.  
nsy-1: Loss of function mutation in nsy-1, the worm homolog for apoptosis signal-
regulating kinase (ASK), protects worms against long-term anoxia (Hayakawa et al., 
2011). nsy-1 encodes a MAP kinase kinase kinase (MAP3K), and its activity is required 
in many cell types such as hypodermis, neurons and intestine, for this phenotype. 
Additionally, a loss of function mutation in MAP2K (sek-1) also improved survival under 
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anoxic conditions. Together, these data point to a global role for the MAPK pathway in 
regulating anoxia in worms.  
hyl-2: Loss of hyl-2, the worm homolog for a ceramide synthase, makes worms 
hypersensitive to anoxia (Menuz et al., 2009). In worms, hyl-2 encodes a ceramide 
synthase responsible for the de novo synthesis of specific ceramides ranging 20-22 
carbon chain lengths. hyl-2 does not depend on apoptosis to induce anoxia sensitivity in 
worms, and loss of daf-2 in hyl-2 mutants partially rescues survival of animals 
suggesting a potential interaction between these two genes in anoxia survival. Overall, 
these data suggest that synthesis of specific ceramides contributes to the worm 
response against anoxic insult. 
skn-1: Loss of function in skn-1, the worm ortholog for nuclear factor-erythroid-related 
factor (Nrf), prevents recovery of worms after anoxic exposure (Ghose et al., 2013). 
Compared to wild type worms, skn-1 mutants had significantly impaired recovery of 
movement 10 minutes post-anoxia (24h exposure). This lack of behavioral recovery 
correlated with increased mitochondrial fission in skn-1 mutant worms, suggesting a role 
for skn-1-mediated response to oxidative stress in regulating mitochondrial dynamics 
under anoxic stress. 
 
Overall, I will explore the bidirectional role of metabolism in disease and stress by 
a) studying how manipulating organismal metabolism can alter progression of a 
neurodegenerative disease (ALS) (Chapter 2) and b) studying the contribution of 
neuropeptide signaling in a physiological state driven by metabolic adaptation to an 
environmental stress (anoxia) (Chapter 3). 
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Abstract 
Dysfunction and death of motor neurons leads to progressive paralysis in 
Amyotrophic lateral sclerosis (ALS). Recent studies have reported organism-level 
metabolic dysfunction as a prominent, but poorly understood feature of the disease. ALS 
patients are hypermetabolic with increased resting energy expenditure, but if and how 
hypermetabolism contributes to disease pathology is unknown. We asked if decreasing 
metabolism in the mutant superoxide dismutase 1 (SOD1) mouse model of ALS (G93A 
SOD1) would alter motor function and survival. To address this, we generated mice with 
the G93A SOD1 mutation that also lacked the melanocortin-4 receptor (MC4R). MC4R is 
a critical regulator of energy homeostasis and food intake in the hypothalamus. Loss of 
MC4R is known to induce hyperphagia and hypometabolism in mice. In the MC4R null 
background, G93A SOD1 mice become markedly hypometabolic, overweight and less 
active. Decreased metabolic rate, however, did not reverse any ALS-related disease 
phenotypes such as motor dysfunction or decreased lifespan. While hypermetabolism 
remains an intriguing target for intervention in ALS patients and disease models, our 
data indicate that the melanocortin system is not a good target for manipulation. 
Investigating other pathways may reveal optimal targets for addressing metabolic 
dysfunction in ALS. 
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Introduction 
Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease 
characterized by loss of upper and lower motor neurons leading to paralysis and death 
(Ferraiuolo et al., 2011; Hardiman et al., 2011; Kiernan et al., 2011; Taylor et al., 2016). 
Work from a variety of models implicates dysfunctional RNA metabolism, protein 
homeostasis, altered mitochondrial function and oxidative stress in disease 
pathophysiology (Ferraiuolo et al., 2011; Robberecht and Philips, 2013; Taylor et al., 
2016). In addition to cell-autonomous factors (i.e., the accumulation of toxic misfolded 
proteins in motor neurons), there is compelling evidence for non-cell autonomous 
processes contributing to disease progression, such as the participation of microglia and 
astrocytes (Wang et al., 2010; O'Rourke et al., 2016). At present these insights into ALS 
have not translated into drugs that substantively influence the course of disease. 
Studies of patients with ALS have provided intriguing evidence for whole 
organism metabolic derangements. For example, glucose intolerance is present in 33% 
of sporadic ALS patients vs. 9.5% in controls (Pradat et al., 2010), hypermetabolism is 
present in 50-60% of ALS patients (Funalot et al., 2009b) and dyslipidemia, measured 
by increased LDL/HDL ratio, is present in 45.4% of ALS patients vs 16.1% in controls 
(Dupuis et al., 2008). ALS patients have lower body mass index (BMI) and lower lean 
body mass compared to healthy controls (Ahmed et al., 2014), and many of these 
perturbations present early in disease and are progressive. There is an inverse 
correlation between premorbid BMI and risk of ALS; in overweight or obese individuals, 
the risk of ALS was reduced 30-40% (O'Reilly et al., 2013). Mouse models of ALS, 
based on known familial mutations such as SOD1, TDP43, FUS and C9ORF72, similarly 
show energetic abnormalities including mitochondrial dysfunction, decreased body 
weight and hypermetabolism (Mattiazzi, 2002; Dupuis et al., 2004; Chiang et al., 2010; 
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Stribl et al., 2014; Perera and Turner, 2015). ALS patients fed a high calorie, high 
carbohydrate diet showed fewer adverse events, delayed weight loss and longer lifespan 
than those fed a control diet (Wills et al., 2014b). Various types of high calorie diets have 
been shown to provide benefits to the mutant SOD mouse model of the disease as well 
(Dupuis et al., 2004; Zhao et al., 2006; Ari et al., 2014). Together, these 
observations provide evidence that organismal metabolism is likely to contribute to the 
pathogenesis of ALS.  
One approach to investigating the contribution of hypermetabolism (an increase 
in resting energy expenditure) to ALS (Bouteloup et al., 2009; Funalot et al., 2009b) is to 
genetically decrease metabolic rate in mouse models of disease. For example, placing 
the G93A SOD1 mice on a leptin deficient background (G93A;ob+/-) lowers organism 
level metabolism (Lim et al., 2014). These mice gain more weight, became 
hypometabolic, have improved motor function as well as longer lifespan compared to 
G93A SOD1 mice alone. However, this study has several inherent limitations. For 
technical reasons, it was not possible to study G93A;ob/ob animals and thus the degree 
of hypometabolism achieved was rather modest. In addition beyond its role in energy 
homeostasis (by controlling feeding and promoting satiety) leptin has myriad additional 
actions, including effects on neuronal development (Ahima et al., 1999; Figlewicz et al., 
2006; Van Doorn et al., 2017). These limitations led us to consider if a different genetic 
manipulation that led to a more pronounced hypometabolic phenotype, and obviated the 
complexities of leptin deficiency, might lead to a greater improvement in the G93A SOD1 
model.  
To this end, we crossed G93A SOD1 mice, henceforth referred to as G93A, to 
those lacking the melanocortin-4 receptor (MC4R), henceforth referred to as MC4R-/-, 
generating double mutant G93A;MC4R-/- mice (see methods and Fig. 2.1a for breeding 
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strategy). We chose this gene since MC4R null mice are shown to be hypometabolic and 
hyperphagic (Huszar et al., 1997; Ste Marie et al., 2000). Additionally, MC4R is a good 
candidate because of its central role in energy homeostasis (Krashes et al., 2016). It is 
expressed in the anterior bed nucleus of the stria terminalis, paraventricular nucleus of 
the hypothalamus and lateral hypothalamus and regulates food intake, metabolic rate 
and body weight. Mice lacking this receptor cannot promote energy expenditure, leading 
to hypometabolism, hyperphagia and weight gain. Our goal was to genetically induce 
hypometabolism in G93A mice by placing them in the MC4R null background, thus 
altering a central component of energy balance, and test the effect of this specific 
manipulation on metabolism, disease progression and survival.  
 
 
Results 
 
G93A mice lacking the melanocortin-4 receptor are obese, hyperphagic and 
lethargic 
 
Body weight. Beginning at P40, WT mice (C57Bl/6) of both sexes gained weight over the 
subsequent 40 weeks (Fig. 2.1b, c). MC4R-/- mice also gained weight over the same 
period, however, they were heavier than WT mice at every recorded time point. For 
example, at week 10 of measurements (P110), female and male WT mice weighed an 
average of 28.3g and 34.9g respectively, while MC4R-/- mice weighed 58.6g and 57.9g 
respectively. G93A mice of both sexes also gained the same amount of weight as WT 
mice until about P103 (9-11 weeks after P40), after which they progressively lost weight 
until they were moribund. G93A;MC4R-/- mice of both sexes gained the same amount of 
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weight as MC4R-/- mice until about P124 (11-12 weeks after P40), after which they 
progressively lost weight until they were moribund. At P110, female and male G93A 
mice weighed an average of 24.9g and 29.2g respectively, while G93A;MC4R-/- mice 
weighed 55g and 53.4g respectively. These results indicate that, as previously reported 
(Huszar et al., 1997; Balthasar et al., 2005), MC4R-/- mice gain significantly more weight 
compared to WT mice as they age, and G93A mice too gain significant weight when 
MC4R function is ablated, in comparison to WT and G93A animals. 
 
Feeding. Next, we used the comprehensive lab animal monitoring system (CLAMS, see 
methods) to study food consumption in these mice over a 24h period at P60, P90 and 
P120 (Fig. 2.1d, e). When all four genotypes (WT, G93A, MC4R-/-, G93A;MC4R-/-) were 
compared, group differences were found by one-way ANOVA for females (P60: F(3,25) = 
4.476, p = 0.012; P90: F(3,21) = 5.924, p = 0.0043; P120: F(3,21) = 1.56, p = 0.2287) and 
males (P60: F(3,19) = 1.311, p = 0.2998; P90: F(3,22) = 3.579, p = 0.0302; P120: F(3,20) = 
1.552, p = 0.232). Female WT mice consumed 3-4g of food over 24h at P60, P90 and 
P120, while male WT mice consumed 4-5g of food at the same times. Female and male 
MC4R-/- mice, in comparison, consumed more food than WT mice (4-5g and 6-7g 
respectively) at these time points but this did not achieve significance in post hoc 
analyses. Female and male G93A mice had similar amounts of food consumption 
compared to WT mice (3-4g and 4-5g respectively), and female and male G93A;MC4R-/- 
mice had similar amounts of food consumption compared to MC4R-/- mice (5g and 5-6g 
respectively). Importantly, female G93A;MC4R-/- mice had significantly greater food 
consumption than G93A mice at P60 and P90 (post hoc, p<0.05 at P60 and p<0.01 at 
P90), but not at P120. Male G93A;MC4R-/- mice consumed more food than G93A mice 
at all age points, but this did not reach statistical significance. These results demonstrate 
27	
	
that WT and G93A mice have similar daily food consumption, and MC4R-/- and 
G93A;MC4R-/- mice have similar daily food consumption that is greater than WT and 
G93A mice.  
 
 
 
Ambulatory activity. We also used the CLAMS to look at ambulatory (non-grooming) 
activity of these mice over 24h at P60, P90 and P120 (Fig. 2.2a, b). Three parameters 
Figure 2.1. Breeding strategy, body weight and food intake in study mice. 
(a) Two step breeding strategy for generating study mice. Parentheses indicate the 
expected genotype frequencies of the progeny in each cross. The relevant animals used 
in this study are represented inside the box in the F2 generation. Body weight 
measurements in female (b) and male (c) WT, G93A, MC4R-/- and G93A;MC4R-/- mice, 
recorded weekly after P40. The vertical dashed lines represent P60, P90 and P120 when 
measurements of food intake, ambulatory activity, metabolic rate and motor function were 
made. Food intake measurements over a 24h period at P60, P90 and P120 in female (d) 
and male (e) mice. Significance measured by one-way ANOVA among genotypes at each 
time point, followed by Tukey’s test for multiple comparisons: p<0.05 (*), p<0.01 (**), 
p,0.001 (***), p<0.0001 (****). 
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were measured at each age: total activity over 24h, activity during the 12h light period 
and activity during the 12h dark period. Group differences within the 4 genotypes (WT, 
G93A, MC4R-/- and G93A;MC4R-/-) were determined using one-way ANOVA at each 
age, followed by post hoc analysis with Tukey’s test for multiple comparisons. 
a) Total Activity. Group differences were found in total activity over 24h at P60, P90 and 
P120 for females (P60: F(3,26) = 9.546, p=0.0002; P90: F(3,24) = 36.55, p<0.0001; P120: 
F(3,23) = 34.36, p<0.0001) and males (P60: F(3,20) = 7.346, p=0.017; P90: F(3,22) = 15.31, 
p<0.0001; P120: F(3,21) = 8.289, p=0.0008). MC4R-/- mice of both sexes were significantly 
less active than WT mice at all three ages (post hoc, p<0.05). G93A mice of both sexes 
were as active as WT mice at all three ages. G93A;MC4R-/- mice of both sexes were as 
active as MC4R-/- mice, and were significantly less active compared to G93A mice at all 
three ages for females and at P90 and P120 for males (post hoc, females p<0.01, males 
p<0.05).  
b) Light Period Activity. Group differences were found in activity of the mice during the 
12h light period at P60, P90 and P120 in females (P60: F(3,25) = 5.328, p=0.0056; P90: 
F(3,22) = 20.76, p<0.0001; P120: F(3,23) = 19.32, p<0.0001) and males (P60: F(3,20) = 7.939, 
p=0.0011; P90: F(3,22) = 4.413, p=0.0142; P120: F(3,21) = 19.51, p<0.0001). MC4R-/- mice 
of both sexes were significantly less active than WT mice at all three ages for females 
and at P60 and P120 for males (post hoc, p<0.05). G93A mice of both sexes had similar 
activity compared to WT mice at all three ages. G93A;MC4R-/- mice of both sexes were 
as active as MC4R-/- mice, and were significantly less active compared to G93A mice at 
P90 and P120 (post hoc, females p<0.001, males p<0.05). 
c) Dark Period Activity. Group differences were found in the activity of the mice during 
the 12h dark period at P60, P90 and P120 in females (P60: F(3,25) = 9, p=0.0003; P90: 
F(3,22) = 28.5, p<0.0001; P120: F(3,23) = 32.57, p<0.0001) and males (P60: F(3,20) = 6.436, 
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p=0.0032; P90: F(3,22) = 17.46, p<0.0001; P120: F(3,20) = 6.302, p=0.0035). MC4R-/- mice 
of both sexes were significantly less active than WT mice at all three ages (post hoc, 
p<0.05). G93A mice of both sexes had similar activity compared to WT mice at all three 
ages. G93A;MC4R-/- mice of both sexes were as active as MC4R-/- mice, and were 
significantly less active compared to G93A mice at P90 and P120 for females and at P90 
for males (post hoc, females p<0.01, males p=0.0001).  
 
 
 
These data indicate that WT and G93A mice have similar activity levels at the 
measured time points both in the light and the dark cycles. During the same periods, 
MC4R-/- mice are significantly less active than WT mice and G93A;MC4R-/- mice have 
similar activity levels as MC4R-/- mice, significantly less than G93A mice alone.  
Figure 2.2. Ambulation in study mice. 
Ambulatory activity measured by beam breaks recorded at P60, P90 and P120 in female (a) 
and male (b) mice. Significance measured by one-way ANOVA among genotypes at each 
time point, followed by Tukey’s test for multiple comparisons: p<0.05 (*), p<0.01 (**), p,0.001 
(***), p<0.0001 (****). 
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In summary, G93A mice begin to lose weight compared to WT mice as they age. 
However, their food intake and activity levels are similar to WT mice at all recorded ages 
and even as they are losing weight, indicating a hypermetabolic phenotype. In all three 
measures - weight gain, food intake and activity level - G93A;MC4R-/- mice are 
indistinguishable from MC4R-/- mice. They are overweight, feed more and have greatly 
reduced activity compared to G93A mice, indicating that ablation of MC4R leads to 
unambiguous and significant phenotypic changes in G93A mice. Manipulating the 
activity of MC4R is thus a reasonable way to induce changes at the whole organism 
level in this mutant SOD1 background. 
 
 
G93A mice lacking the melanocortin-4 receptor are hypometabolic 
 
In order to determine metabolic flux in test mice over time, we measured average 
total oxygen consumption and carbon dioxide production per hour, per kg over a 24h 
period at the three different ages (P60, P90 and P120) using indirect calorimetry by the 
CLAMS (Fig. 2.3a, b). We also looked at the O2 consumption and CO2 production during 
the 12h light period (Fig. 2.4a, b) and 12h dark period (Fig. 2.5a, b) within the 24h 
recording. Group differences between the genotypes (WT, G93A, MC4R-/- and 
G93A;MC4R-/-) were determined using one-way ANOVA at each age, followed by post 
hoc analysis with Tukey’s test for multiple comparisons. 
 
Total O2 consumption (Fig. 2.3a). Group differences in O2 consumption over 24h were 
found at P60, P90 and P120 for females (P60: F(3,25) = 5.259, p=0.0060; P90: F(3,22) = 
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13.61, p<0.0001; P120: F(3,24) = 17.07, p<0.0001) and males (P60: F(3,20) = 3.3916, 
p=0.0238; P90: F(3,22) = 2.434, p=0.0919; P120: F(3,21) = 9.607, p=0.0003). Female 
MC4R-/- mice had significantly less O2 consumption than WT mice at P90 and P120 
(post hoc, p<0.05), while male MC4R-/- mice had decreased O2 consumption compared 
to WT mice at all three ages but this did not achieve significance. Female G93A mice 
had significantly more O2 consumption than WT mice at P90 (post hoc, p<0.05), 
whereas male G93A mice had increased O2 consumption compared to WT mice at P60 
and P120 but this did not achieve significance. G93A;MC4R-/- mice of both sexes were 
similar compared to MC4R-/- mice, and had significantly less O2 consumption compared 
to G93A mice at all three ages for females and at P60 and P120 for males (post hoc, 
females p<0.01, males p<0.05).  
 
Total CO2 production (Fig. 2.3b). Group differences in CO2 production over 24h were 
found at P60, P90 and P120 for females (P60: F(3,25) = 4.258, p=0.0147; P90: F(3,22) = 
10.67, p=0.0002; P120: F(3,24) = 15.85, p<0.0001) and males (P60: F(3,20) = 3.852, 
p=0.0252; P90: F(3,22) = 1.681, p=0.2002; P120: F(3,21) = 6.699, p=0.0024). Female 
MC4R-/- mice had significantly less CO2 production than WT mice at P120 (post hoc, 
p<0.05), while male MC4R-/- mice had decreased CO2 production than WT mice at all 
three ages but this was not statistically significant. Female G93A mice had significantly 
greater CO2 production than WT mice at P90 (post hoc, p<0.05), whereas male G93A 
mice had increased CO2 production compared to WT mice at P60 and P90 but this was 
not statistically significant. G93A;MC4R-/- mice of both sexes were similar compared to 
MC4R-/- mice, but had significantly less CO2 production compared to G93A mice at all 
three ages for females and at P60 and P120 for males (post hoc, p<0.05 for females and 
males). 
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Light Period O2 consumption (Fig. 2.4a). Group differences in oxygen consumption 
during the12h light period were found at P60, P90 and P120 for females (P60: F(3,25) = 
3.271, p=0.0378; P90: F(3,22) = 7.161, p=0.0016; P120: F(3,24) = 10.16, p=0.0002) and 
males (P60: F(3,20) = 1.16, p=0.3498; P90: F(3,22) = 0.747, p=0.5357; P120: F(3,21) = 5.867, 
p=0.0045). Female MC4R-/- mice had significantly less O2 consumption than WT mice at 
P120 (post hoc, p<0.05), while males had decreased O2 consumption compared to WT 
mice at P60 and P120, but this was not significant. Female G93A mice had significantly 
greater O2 consumption than WT mice at P90 (post hoc, p<0.05), whereas male G93A 
mice had increased O2 consumption compared to WT mice at P120, but this was not 
Figure 2.3. Oxygen consumption and carbon dioxide production over one day 
(24h) in study mice. 
Total O2 consumption (a) and CO2 production (b) in female and male WT, G93A, 
MC4R-/- and G93A;MC4R-/- mice at P60, P90 and P120 measured in mL, per hour, 
per kg mass of the animal over 24 hours of recording, including light and dark cycles. 
Significance measured by one-way ANOVA among genotypes at each time point, 
followed by Tukey’s test for multiple comparisons: p<0.05 (*), p<0.01 (**), p,0.001 
(***), p<0.0001 (****). 
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significant. G93A;MC4R-/- mice of both sexes were similar compared to MC4R-/- mice, 
but had significantly less O2 consumption compared to G93A mice at all three ages for 
females and at P120 for males (post hoc, females p<0.05, males p<0.05). 
 
Light Period CO2 production (Fig. 2.4b). Group differences in CO2 production during the 
12h light period were found at P60, P90 and P120 for females (P60: F(3,25) = 3.337, 
p=0.0354; P90: F(3,22) = 5.136, p=0.0076; P120: F(3,24) = 10.79, p=0.0001) and males 
(P60: F(3,20) = 1.326, p=0.2939; P90: F(3,22) = 0.4866, p=0.6951; P120: F(3,21) = 5.126, 
p=0.0081). MC4R-/- mice of both sexes had decreased CO2 production than WT mice at 
P60 and P120 but this was not statistically significant. G93A mice had increased CO2 
production compared to WT mice at P90 and P120 in females and P120 in males but 
this was not statistically significant. G93A;MC4R-/- mice of both sexes were similar 
compared to MC4R-/- mice, but had significantly less CO2 production compared to G93A 
mice at all three ages for females and at P120 for males (post hoc, p<0.05 for females 
and males). 
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Dark Period O2 consumption (Fig. 2.5a). Mice of all genotypes had increased O2 
consumption in the dark compared the light period, consistent with their increased 
nocturnal activity. Group differences in O2 consumption during the 12h dark period were 
found at P60, P90 and P120 for females (P60: F(3,25) = 6.772, p=0.0017; P90: F(3,22) = 
29.86, p<0.0001; P120: F(3,24) = 24.78, p<0.0001) and males (P60: F(3,20) = 9.646, 
p=0.0004; P90: F(3,22) = 9.709, p=0.0003; P120: F(3,21) = 11.98, p<0.0001). MC4R-/- mice 
of both sexes had significantly less O2 consumption than WT mice, at P90 and P120 for 
females and at P120 for males (post hoc, females p<0.01, males p<0.05). Female G93A 
mice had significantly greater O2 consumption than WT mice at P90 (post hoc, p<0.05), 
whereas male G93A mice had increased O2 consumption compared to WT mice at P60 
Figure 2.4. Oxygen consumption and carbon dioxide production during the 12h 
light cycle in study mice. 
Light cycle O2 consumption (a) and CO2 production (b) in female and male WT, G93A, 
MC4R-/- and G93A;MC4R-/- mice at P60, P90 and P120 measured in mL, per hour, per kg 
mass of the animal over 12 hours of recording during the light cycle of the day. 
Significance measured by one-way ANOVA among genotypes at each time point, 
followed by Tukey’s test for multiple comparisons: p<0.05 (*), p<0.01 (**), p,0.001 (***). 
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and P120, but this was not statistically significant. G93A;MC4R-/- mice of both sexes 
were similar compared to MC4R-/- mice, and had significantly less O2 consumption 
compared to G93A mice at all three ages (post hoc, p<0.01).  
 
Dark Period CO2 production (Fig. 2.5b). Similar to O2 consumption, mice of all genotypes 
had increased CO2 production in the dark compared the light period, consistent with their 
increased nocturnal activity. Group differences in CO2 production during the 12h dark 
period were found at P60, P90 and P120 for females (P60: F(3,25) = 4.646, p=0103; P90: 
F(3,22) = 20.56, p<0.0001; P120: F(3,24) = 19.56, p<0.0001) and males (P60: F(3,20) = 8.061, 
p=0.0010; P90: F(3,22) = 3.994, p=0.0206; P120: F(3,21) = 6.135, p=0.0037). Female 
MC4R-/- mice had significantly less CO2 production than WT mice at P90 and P120 (post 
hoc, p<0.05), whereas male MC4R-/- mice had decreased CO2 production compared to 
WT mice at all ages but this was not statistically significant. Female G93A mice had 
significantly increased CO2 production compared to WT mice at P90 (post hoc, p<0.05), 
while male G93A mice had increased CO2 production compared to WT mice at P60 and 
P120 but this was not statistically significant. G93A;MC4R-/- mice of both sexes were 
similar compared to MC4R-/- mice, but had significantly less CO2 production compared to 
G93A mice at all three ages (post hoc, p<0.05 for females and males). 
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Together, these data from indirect calorimetry suggest that compared to WT 
animals, G93A mice display a moderately higher metabolic rate and that MC4R-/- mice 
are hypometabolic. Interestingly, both the G93A hypermetabolism and the MC4R-/- 
hypometabolism is more striking in females than in males, and when the animals are in 
the dark. When G93A mice are placed in the MC4R-/- background, their metabolic profile 
is similar to MC4R-/- mice alone, for both males and females. G93A;MC4R-/- mice are 
significantly more hypometabolic compared to G93A mice in both dark and light periods. 
This suggests that MC4R ablation, in addition to affecting weight, food intake and 
activity, can also rescue the hypermetabolic phenotype in this mutant SOD1 model of 
ALS. 
Figure 2.5. Oxygen consumption and carbon dioxide production during the 12h 
dark cycle in study mice. 
Dark cycle O2 consumption (a) and CO2 production (b) in female and male WT, 
G93A, MC4R-/- and G93A;MC4R-/- mice at P60, P90 and P120 measured in mL, per 
hour, per kg mass of the animal over 12 hours of recording during the dark cycle of 
the day. Significance measured by one-way ANOVA among genotypes at each time 
point, followed by Tukey’s test for multiple comparisons: p<0.05 (*), p<0.01 (**), 
p,0.001 (***), p<0.0001 (****). 
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G93A mice lacking the melanocortin-4 receptor do not have improved motor 
function 
 
 Motor function of G93A mice deteriorates over time (Feeney et al., 2001). We 
asked if induction of hypometabolism blunted this age dependent phenotype. To this 
end, we measured forelimb and hindlimb grip strength in male and female study mice at 
P60, P90 and P120.  
 
Forelimb Strength (Fig. 2.6a). Group differences in forelimb grip strength among 
genotypes (WT, MC4R-/-, G93A, G93A;MC4R-/-) were found using one-way ANOVA at 
each age point for females (P60: F(3,27) = 1.724, p=0.1856; P90: F(3,29) = 12.77, p<0.0001; 
P120: F(3,30) = 50.14, p<0.0001) and males (P60: F(3,24) = 9.174, p=0.0003; P90: F(3,26) = 
15.69, p<0.0001; P120: F(3,29) = 66.43, p<0.0001).  
 MC4R-/- mice of both sexes had similar forelimb grip strength compared to WT 
mice at all three ages. G93A mice of both sexes had significantly decreased forelimb 
grip strength compared to WT mice, at P90 and P120 for females and at all three ages 
for males (post hoc, females p<0.001, males p<0.01). G93A;MC4R-/- mice of both sexes 
had significantly decreased forelimb grip strength than MC4R-/- mice at P90 and P120 
(post hoc, females p<0.001, males p<0.01), and had similar forelimb grip strength 
compared to G93A mice at all three ages. The only exception was that female 
G93A;MC4R-/- mice had significantly improved grip strength compared to G93A mice at 
P120 (post hoc, p<0.05). 
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Hindlimb Strength (Fig. 2.6b). Group differences in hindlimb grip strength among 
genotypes (WT, MC4R-/-, G93A, G93A;MC4R-/-) were found using one-way ANOVA at 
each age point for females (P60: F(3,27) = 12.66, p<0.0001; P90: F(3,29) = 25.69, p<0.0001; 
P120: F(3,30) = 57.73, p<0.0001) and males (P60: F(3,24) = 7.494, p=0.0010; P90: F(3,26) = 
26.7, p<0.0001; P120: F(3,29) = 68.35, p<0.0001).  
 MC4R-/- mice of both sexes had similar hindlimb grip strength compared to WT 
mice at all three ages, with one exception: male MC4R-/- mice had significantly increased 
hindlimb strength compared to WT mice at P120 (post hoc, p=0.0051). G93A mice of 
both sexes had progressively worsening hindlimb grip strength with age, and this was 
significantly decreased compared to WT mice at all three ages (post hoc, females 
p<0.001, males p<0.05). This difference was larger as the animals aged, at P90 and 
P120. G93A;MC4R-/- mice of both sexes had significantly decreased hindlimb grip 
strength than MC4R-/- mice all three ages (post hoc, p<0.05). Although female 
G93A;MC4R-/- mice had increased hindlimb grip strength compared to G93A mice at all 
ages, this did not achieve significance. Male G93A;MC4R-/- mice had similar hindlimb 
grip strength compared to G93A mice at all three ages.  
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These experiments show that G93A mice have significantly less forelimb and 
hindlimb grip strength compared to WT mice, indicating progressively impaired motor 
function. Importantly, although G93A;MC4R-/- mice are similar to MC4R-/- mice in their 
hypometabolic phenotype, they are significantly worse than MC4R-/- mice in grip 
strength. In fact, male G93A;MC4R-/- mice are indistinguishable from G93A mice in grip 
Figure 2.6. Motor function and survival of study mice. 
Forelimb (a) and hindlimb (b) grip strength of female and male WT, G93A, MC4R-/- and 
G93A;MC4R-/- mice measured at P60, P90 and P120. Significance measured by one-
way ANOVA among genotypes at each time point, followed by Tukey’s test for multiple 
comparisons: p<0.05 (*), p<0.01 (**), p,0.001 (***), p<0.0001 (****). Kaplan-Meier 
survival plots (c) of female and male study mice. Significance was calculated using the 
log-rank (Mantel-Cox) test for survival curve comparison between G93A and 
G93A;MC4R-/- mice, and was set to p<0.05. 
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strength. In females, there is significantly improved forelimb strength at P120 in 
G93A;MC4R-/- mice compared with G93A mice, and there is a consistent trend in 
improved hindlimb strength at all time points. Therefore, MC4R ablation has no effect on 
the motor function of male G93A mice and has a modest effect in female G93A mice. 
 
 
G93A mice lacking the melanocortin-4 receptor do not have extended lifespan 
  
Finally we looked at the lifespan of our mice. WT and MC4R-/- mice had similar 
longevity and no animals of these genotypes died within 1 year of birth. In agreement 
with published work, we found male and female G93A mice had a severely shortened 
lifespan compared to WT mice (Gurney et al., 1994), with a median survival of 169.5 
days and 167 days respectively (Fig. 2.6c). There was no significant difference in the 
lifespan of G93A;MC4R-/- mice compared to G93A mice. Median survival in these mice 
was 162 days and 164.5 days for males and females respectively (Fig. 2.6c). Although 
the double mutant G93A;MC4R-/- mice reach the pre-determined euthanasia criteria at 
the same time as G93A mice, they continue to have significantly higher body weight than 
the G93A mice at end stage (Fig. 2.1b, c). Together, these data suggest that ablation of 
melanocortin-4 receptor does not significantly prolong the life span of the G93A mouse.  
 
 
The leptin-MC4R pathway is altered in mice lacking the melanocortin-4 receptor  
  
 In addition to their role in controlling food intake and organismal metabolism, 
peptide hormones that impinge upon the MC4R signaling pathway can display beneficial 
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neuronal activities. In its canonical role in regulating metabolism, leptin acts on two 
populations of neurons in the arcuate nucleus of the hypothalamus: the 
proopiomelanocortin (POMC)-producing neurons and the agouti-related peptide (AgRP)-
producing neurons (Krashes et al., 2016). The POMC derived α-melanocyte stimulating 
hormone (α-MSH) is an agonist and AgRP is an antagonist of the MC4R. When calories 
are replete, α-MSH activates MC4R to promote satiety, feeding suppression, and weight 
loss by energy expenditure. When calories are depleted AgRP antagonizes MC4R to 
promote energy consumption and blunt energy expenditure. With regard to beneficial 
neuronal activities, α-MSH can promote cognitive recovery in a mouse model of 
Alzheimer’s disease (Ma and McLaurin, 2014) and demonstrates general anti-
inflammatory properties (Caruso et al., 2007; Brzoska et al., 2008). Similarly, higher 
circulating leptin is associated with decreased risk of Alzheimer’s disease and protection 
against cognitive decline (Holden et al., 2009). Due to their varied actions, we asked if 
the expression of serum leptin and α-MSH might be altered in G93A and MC4R-/- 
animals in order to clarify the role of these peptides in our experiments.   
We measured plasma concentrations of leptin and α-MSH in adult male WT, 
MC4R-/- and G93A mice. α-MSH levels were decreased in both MC4R-/- and G93A mice 
compared to WT (Fig. 2.7a), but this did not achieve significance (p = 0.08 for MC4R-/- 
and p = 0.16 for G93A). Leptin levels are moderately decreased in G93A mice (Fig 3.7b) 
and markedly increased in MC4R-/- mice compared to WT animals (p < 0.0001), 
consistent with the increased body weight and adiposity of these animals (Fig. 2.1).  As 
seen in previous work (Dupuis et al., 2004; Lim et al., 2014), leptin levels were 
decreased in G93A mice compared to WT mice. The modest difference in α-MSH levels 
among the genotypes may indicate relatively little contribution of the extra-metabolic 
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effects of this hormone on neuronal health. The markedly elevated leptin levels in the 
absence of MC4R may indicate a healthful compensatory hormonal response, although if 
so, it does not improve motor function or extend life of the G93A mice. In light of the 
benefits of haploinsufficiency of leptin demonstrated by Lim et al (Lim et al., 2014), it is 
conceivable that increased leptin in the absence of MC4R actually mitigates any 
potential benefits of hypometabolism. 
 
 
 
 
 
 
 
Figure 2.7. The leptin-MC4R pathway in G93A SOD1 mice. 
Plasma α-MSH (a) and leptin (b) concentrations in adult male WT, MC4R-/- mice (n=3 for 
each genotype). Significance measured by one-way ANOVA among genotypes, 
followed by Tukey’s test for multiple comparisons: p<0.0001 (****). (c) Summary of 
alterations in leptin, α-MSH/POMC cells and AgRP/AgRP cells in *G86R SOD1 mice 
(Vercruysse et al, 2016) and G93A SOD1 mice. (d) Speculative model of the leptin-
MC4R pathway in G93A;MC4R-/- mice based on data from MC4R-/- mice. 
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Discussion 
An increase in resting energy expenditure, or hypermetabolism, is a distinct 
organism-level feature of ALS patients and mouse models (Dupuis et al., 2004; Funalot 
et al., 2009a; Dupuis et al., 2011; Tefera and Borges, 2017). Our goal was to generate 
an ALS model mouse that was hypometabolic, and test the effect of this manipulation on 
key features of disease. In order to induce hypometabolism, we ablated MC4R function 
because it is a central regulator of energy metabolism. We successfully generated and 
studied mice that are null for MC4R and bear the ALS-linked G93A mutation in the 
SOD1 gene. We make two principal observations. First, the G93A;MC4R-/- animals are 
markedly hypometabolic as reported by weight gain and indirect calorimetry. Thus the 
G93A mutation does not impede the central regulation of metabolism via MC4R. 
Second, despite evoking hypometabolism in the G93A animals, the most important 
measures of disease (e.g., motor function and longevity) are unaffected. This argues 
that genetic blunting of the hypermetabolic phenotype by manipulation of MC4R is an 
ineffective intervention for slowing disease progression. 
 
Different mechanisms of inducing hypometabolism in ALS 
Prior studies in the G93A mouse model have shown that hypermetabolism does 
contribute to disease progression, and we highlight two of them here. In 2004, Dupuis et 
al studied male mice in two different ALS-related mutant SOD1 mouse models, G86R 
and G93A (Dupuis et al., 2004). They found that in both models, mice had lower body 
weight and increased energy expenditure by indirect calorimetry compared to age 
matched littermate controls. When the G86R mice were fed a high fat diet consisting of 
regular chow supplemented with 21% butterfat and 0.15% cholesterol, they gained 
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significantly more weight and had increased fat deposits than those fed regular chow 
alone. The high fat diet was associated with slowed motor neuron loss, slowed muscle 
denervation and a 20% improvement in mean lifespan. In 2014, Lim et al showed that 
the G93A mice were hypermetabolic and decreasing leptin levels (by placing them in a 
heterozgous ob+/- background), led to hypometabolism and weight gain in these mice 
(Lim et al., 2014). Leptin deficiency also led to improved hindlimb grip strength and led to 
a female-specific increase in median lifespan. These studies demonstrate that 
ameliorating the hypermetabolic phenotype, either by diet or by a specific genetic 
manipulation, can blunt the progression of ALS-like phenotypes in mutant SOD1 models 
of ALS. 
What does the difference between our current results with MC4R and prior work 
by Dupuis et al and Lim et al tell us about the contribution of hypometabolism to ALS? 
To address this, it is worth considering leptin and its interaction with MC4R. Leptin is a 
circulating hormone that plays a prominent role in controlling food intake and satiety 
(Cone, 2005; Krashes et al., 2016). It is released by adipocytes and acts on specific 
neurons in the arcuate nucleus of the hypothalamus. These first order neurons then act 
on second order neurons in the lateral hypothalamus and the paraventricular nucleus of 
the hypothalamus. MC4R is expressed on the second order neurons that receive 
opposing inputs based on upstream leptin signaling. When calories are replete, leptin-
mediated MC4R activation promotes satiety and energy expenditure. When calories are 
depleted, circulating leptin is reduced and MC4R is inhibited leading to food 
consumption and suppression of energy expenditure. On the surface, the leptin deficient 
G93A;ob+/- mice Lim et al studied and the G93A;MC4R-/- mice we studied are similar; 
they are both heavier than G93A mice and are hypometabolic. Despite this similarity, it is 
surprising that ablating MC4R, leptin’s downstream target, does not confer the same 
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benefits on motor function as reduced leptin signaling does. One possibility is that the 
beneficial effects of reduced leptin signaling acts via MC4R independent pathways. 
Indeed, leptin receptors are expressed in extrahypothalamic neurons in the midbrain and 
the cerebellum and in peripheral tissue such as the liver (Cohen et al., 2005; Oldreive et 
al., 2008; Davis et al., 2011; Forero-Vivas and Hernández-Cruz, 2014) although the 
function of leptin signaling in extrahypothalamic tissues is not well understood. The 
reduction in circulating leptin that Lim et al achieved in the ob+/- background may point to 
important effects of leptin not captured by MC4R ablation. In light of this, we show here 
that mice lacking MC4R have a 20-30 fold increase in circulating leptin and perhaps this 
mitigates any potential benefit of hypometabolism induced by loss of MC4R.   
 
The hypothalamic melanocortin pathway in ALS 
Recent work indicates intrinsic abnormalities in hypothalamus in ALS. Gorges 
and colleagues find significant atrophy of the hypothalamus in sporadic and familial ALS 
patients (Gorges et al., 2017). Atrophy presents in presymptomatic stages in familial 
mutation carriers and is more severe in patients with lower BMI. This suggests that 
changes in the hypothalamus precede changes in metabolism in ALS patients. In a 
different study, Vercruysse and colleagues looked specifically at the hypothalamic 
melanocortin system in ALS patients and the G86R mutant SOD1 mouse model 
(Vercruysse et al., 2016). In the G86R SOD1 mice, there are significantly fewer first 
order, MC4R-activating (POMC-expressing) neurons and significantly more first order, 
MC4R-inhibiting (AgRP containing) neurons compared to WT mice. These differences 
were observed at pre-symptomatic stages and suggest that signaling in the melanocortin 
system is downregulated in this ALS model. We too find changes in the MC4R signaling 
pathway (e.g., leptin and α-MSH are decreased in G93A mice, Fig. 2.7a and b), although 
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we studied the G93A SOD1 model. To test the idea that evoking a hypometabolic state 
would be beneficial, Vercruysse et al administered an inhibitor of the melanocortin 
system, pioglitazone. This did not lead to weight gain in a clinical trial of ALS patients 
and did not lead to increased food intake by the G86R SOD1 mice. Vercruysse et al 
attributed the lack of efficacy of pioglitazone to the intrinsic abnormalities in melanocortin 
system. On the other hand we show that deletion of MC4R in the G93A mouse can 
clearly evoke hypometabolism, regardless of the state of the melanocortin system in 
ALS. Vercruysse et al did not study G93A mice, but our data suggest that even if 
Vercruysse et al could pharmacologically inhibit melanocortin system and evoke a 
hypometabolic state, it may not lead to a meaningful effect on weakness in these 
models.  
Together, this study, Vercruysse et al (2016), Dupuis et al (2004) and Lim et al 
(2014) show that leptin levels are lower in mutant SOD1 mice, there are fewer POMC 
neurons, more AgRP neurons and lower trending α-MSH (Fig. 2.7c). Given that loss of 
MC4R leads to a large increase in leptin levels, we speculate that contrary to G93A 
mice, leptin levels are also upregulated in the G93A;MC4R-/- mice while α-MSH levels 
are lowered (Fig. 2.7d). If this is in fact the case, our study also suggests that 
upregulating leptin in mutant SOD1 mice may not be beneficial in altering disease 
course. 
 
Sex, metabolism and ALS 
Differences between males and females may contribute to the effectiveness of 
metabolic manipulations in ALS. We find a small but significant female-specific 
improvement in forelimb grip strength at P120 in G93A;MC4R-/- mice. In the leptin study, 
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Lim et al showed that the increase in median lifespan in G93A;ob+/- mice compared to 
G93A mice was female-specific. Dupuis et al only used male mice in their high-fat diet 
experiments, but a recent study showed that a diet with low unsaturated fatty acids led to 
female-specific decrease in median lifespan and a worsening of disease progression in 
G93A mice (Cacabelos et al., 2014). Similarly, metabolic manipulations are shown to 
affect male and female animals differently in other ALS studies (Kaneb et al., 2011; Kim 
et al., 2012; Eschbach et al., 2013; Lim et al., 2014).  
In our study, male MC4R-/- mice have 22% lower O2 consumption and 16% lower 
CO2 production at P120 compared to WT mice in the active, dark period. In contrast, 
female MC4R-/- mice at the same age and time of day have 37% lower O2 consumption 
and 33% lower CO2 production than WT mice. This clearly shows a stronger MC4R 
mediated hypometabolic phenotype in females. The results are similar in the G93A 
background. Male G93A;MC4R-/- double mutant mice have 18% lower O2 consumption 
and 16% lower CO2 production than WT mice at P120 in the dark. In contrast, female 
G93A;MC4R-/- mice have 38% lower O2 consumption and 37% lower CO2 production 
than WT mice at the same age and phase of day. This indicates that even in the G93A 
background, loss of MC4R has a stronger hypometabolic effect in females, which 
coincides with improved forelimb strength in females at the same age. Lim et al found 
that G93A females had similar circulating leptin as WT mice while G93A males had 
decreased circulating leptin compared to WT (Lim et al., 2014). Higher baseline leptin in 
female mice may contribute to their differential response to metabolic manipulations in 
the Lim et al study and this study. These observations highlight sex-specific 
perturbations in metabolism and ALS.  
There are well-documented metabolic differences between males and females, 
including effects of sex hormones such as estrogen and testosterone (Salehzadeh et al., 
48	
	
2011; Mauvais-Jarvis et al., 2013), differences in fat storage (Fried et al., 2015) and food 
intake (Hallam et al., 2016), to name a few. As highlighted above with leptin, metabolic 
differences are also present between males and females in ALS. In addition, there are 
sex-specific differences in ALS presentation and progression. The overall incidence of 
ALS is higher in males than in females, and spinal cord onset is more likely in males 
while bulbar onset is more likely in females (McCombe and Henderson, 2010). In G93A 
mice, females have later onset and longer survival in different genetic backgrounds 
(Heiman-Patterson et al., 2005), females have preferentially upregulated 
proteasomal activity (Riar et al., 2017) and loss of certain genes like PGC-1α 
accelerates disease progression in males but not females (Eschbach et al., 2013). The 
complex interaction of metabolic differences with pathophysiology and the differences in 
metabolism and disease progression in ALS are just beginning to be studied. It is 
therefore important to address male and female subjects differently in any ALS study, 
and especially those that perturb metabolism. 
 
 The G93A SOD1 mouse model of ALS 
Different features of ALS in patients may not be recapitulated in every model of 
the disease. Here, we chose the G93A SOD1 mouse since it is the most widely studied 
model of ALS. These mice mimic many of the clinical features of the disease in patients, 
including hypermetabolism. Unfortunately, there is no systematic study of the level of 
hypermetabolism specifically in patients with SOD1 mutations. Hence, it is not known 
whether the hypermetabolism in the SOD1 mouse model mimics patient symptoms. 
However, a small study showed that patients with familial ALS have a higher incidence 
of hypermetabolism than those with sporadic ALS (Funalot et al., 2009a), and SOD1 
mutations comprise up to 20% of familial ALS cases. Detailed analysis of the metabolic 
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abnormalities in different SOD1 mutations both in patients and in mouse models will help 
in designing and interpreting studies of the contribution of metabolism in ALS.   
Further, the mutant SOD1 strain we used expresses high levels of the human 
G93A SOD1 transgene, leading to a 4-fold increase in SOD1 activity (Gurney et al., 
1994). Compared to other mouse models with different mutations in SOD1, this line has 
earlier symptom onset (13-17 weeks) and shorter lifespan (17-26 weeks). In contrast, 
the G85R mutant SOD1 mouse model has a later symptom onset (35-43 weeks) and 
longer lifespan (37-45 weeks) (Bruijn et al., 1997). It is conceivable that the more 
aggressive presentation of ALS-like symptoms in the G93A mouse blunts the potential 
therapeutic benefit of hypometabolism. Dupuis et al described a hypermetabolic 
phenotype in G93A and G86R mutant SOD1 mice, both of which have earlier onset of 
symptoms and short lifespans (Dupuis et al., 2004), but it is unknown if the G85R mice 
have a hypermetabolic phenotype. It is thus important to determine the hypermetabolic 
phenotype in the G85R SOD1 model, and if it exists, to test the effect of lowering 
organismal metabolism in that model. 
 
Molecular mechanisms of hypermetabolism in mutant SOD1-linked ALS 
Despite decades of effort, the mechanism by which mutant SOD1 causes motor 
neuron death remains unclear. However, accumulating data suggests that soluble, and 
not aggregated, misfolded mutant SOD1 could lead to cellular damage by promiscuous 
interactions with different molecular pathways, including mitochondrial dysfunction and 
reactive oxygen species production (Parone et al., 2013). Damaged mitochondria can 
thus affect cellular metabolism, and by extension organismal metabolism. It is plausible 
that misfolded, soluble mutant SOD1 in the G93A mice is not affected by ablating MC4R 
and is therefore unable to change disease progression in these mice. Indeed, it is not 
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known if metabolic changes are caused by disease-linked mutations or if metabolism is 
distinct from underlying mutations given the prevalence of aberrant metabolism in 
sporadic ALS patients.  
 
Conclusion 
While experiments have shown that weight gain, increasing BMI, and decreasing 
energy expenditure are associated with lower risk for developing ALS (Paganoni et al., 
2011; O'Reilly et al., 2013; Ngo et al., 2014), not all genetic manipulations for inducing 
weight gain and altering metabolism are equal in their effectiveness. The findings 
presented here add to the growing understanding of how energetic dysfunction is 
coupled to ALS. It is critical to understand the metabolic profile in ALS thoroughly, and to 
detail exactly how different dietary and genetic changes influence metabolism in ALS in 
a sex-specific way in order to design appropriate therapeutic interventions.  
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Methods 
Mouse strains and husbandry 
Male hemizygous G93A mutant SOD1 mice (G93A+/-) on the C57BL/6 
background (Strain #004435, Jackson Laboratories, Bar Harbor, ME), referred to as 
G93A, were crossed with female heterozygous loxTB MC4R mice (MC4R+/-) in the 
C57BL/6 background (Balthasar et al., 2005) (Strain #006414, Jackson Laboratories, 
Bar Harbor, ME). The G93A mice carry one copy of the human G93A mutant SOD1 
transgene, and the MC4R+/- mice contain a transcriptional block cassette before the 
MC4R start codon. From the F1 progeny, G93A;MC4R+/- males were crossed with 
MC4R+/- females. From the F2 generation, the following groups were used for study 
purposes: WT (+/+), G93A, MC4R-/-, G93A;MC4R-/- (Fig. 2.1a). Both males and females 
from each group were used for all study parameters. Genotypes were determined by 
PCR using tail snip DNA using the following primers – MC4R: 
GCAGTACAGCGAGTCTCAGG (wild type forward), CTCCCACAGGCTTATGACACC 
(wild type reverse), GTGCAAGTGCAGGTGCCAG (mutant), and SOD1: 
CTAGGCCACAGAATTGAAAGATCT (genomic forward), 
GTAGGTGGAAATTCTAGCATCATCC (genomic reverse), 
CATCAGCCCTAATCCATCTGA (transgene forward), CGCGACTAACAATCAAAGTGA 
(transgene reverse).  
Mice were housed at 22°C with a 12-hour light dark cycle. They were fed 
standard diet (23% protein, 22% fat, 55% carbohydrates). Animals were weighed once a 
week at the same time of day starting at P40 for at least 20 weeks. Mice without the 
G93A mutation were measured for over 40 weeks. All animal protocols were approved 
by the Institutional Animal Care and Use Committee (IACUC) at the Children’s Hospital 
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of Philadelphia, and animals were treated in accordance with the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals.  
 
Study Design 
 Mice of both sexes with four genotypes (WT, G93A, MC4R-/-, G93A;MCR4-/-) 
were studied. The following parameters were measured at P60, P90 and P120: oxygen 
consumption, carbon dioxide production, food consumption, ambulatory activity, forelimb 
strength and hindlimb strength. P60 is shown to be presymptomatic in G93A mice, while 
P90 is symptomatic and P120 is close to end stage (Saxena et al., 2009). We chose 
these time points in order to monitor progression of ALS-related and metabolic 
phenotypes as animals age. Animals were sacrificed when they were unable to right 
themselves within 30 seconds from being supine, and this was recorded as day of death 
for survival measurements.  
 
Weight gain, food consumption, activity and metabolic measurements 
 Food consumption, ambulatory activity and metabolic measurements were made 
at the appropriate time points (P60, P90 and P120) using the Comprehensive Laboratory 
Animal Monitoring System (CLAMS) (Columbus Instruments, Columbus OH). Animals 
were weighed and placed in individual chambers with food and water for 48 hours. Food 
consumption was measured in grams by recording the decrease in weight of the pre-
measured food provided in the chambers. Ambulatory activity was measured in arbitrary 
units by the number of infrared beam breaks in the x-y plane of the cage every minute, 
thus ruling out grooming-related activity in the z-axis. Oxygen consumption and carbon 
dioxide production were measured by indirect calorimetry approximately every 10 
minutes and reported in milliliters per hour, normalized by the body weight of the animal 
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(mL/hr/kg). Animals were allowed to acclimate to the chambers for the first 24 hours, and 
only the data from the final 24 hours was used for analysis.  
 
Motor Output 
 Grip strength measurements were made at the same time of day at appropriate 
time points for the fore and hind paws using a digital grip strength meter (Columbus 
Instruments, Columbus, OH). For fore grip measurements, animals were allowed to grip 
a bar with their fore paws while being held by their tails, and gently pulled back until they 
let go of the bar. The meter recorded the force (in kilogram-force or kgf) with which they 
hold on to the bar as they are pulled back. Similarly, hind grip strength was measured as 
mice gripped a bar with their hind paws. For each animal, one set of trials comprised 3-5 
consecutive trials, and each set was repeated three times, with approximately 3 minutes 
between sets for the animal to rest. The average strength for the 12-15 trials was 
reported for both the fore and the hind paws at each time point.  
 
Plasma leptin and α-MSH measurements 
 Mice were anesthetized using carbon dioxide and cardiac extraction was 
immediately performed to collect blood from adult WT, G93A and MC4R-/- male mice. 
Blood was spun down at 2000g for 20 minutes and supernatant plasma was frozen at -
80C until further use. Plasma concentrations of leptin and α-MSH were determined by 
the Radioimmunoassay and Biomarkers Core facility at the University of Pennsylvania 
using standard ELISA (Leptin: Cat # 22-LEPMS-E01 from ALPCO, Salem NH; α-MSH: 
Cat # MBS2516107 from MyBioSource, San Diego CA). 
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Statistics 
 Data were analyzed using Prism (GraphPad Software, La Jolla, CA). Unless 
otherwise noted, significant differences within groups were determined using one-way 
ANOVA followed by Tukey’s test for multiple comparisons. Survival curves were 
analyzed using the log-rank (Mantel-Cox) test for significance. For all tests, the 
significance threshold was set to p < 0.05. 
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Abstract 
Oxygen deprivation, even for short durations, can be extremely injurious to cells. 
Neurons are particularly vulnerable to changes in oxygen, and cerebral hypoxia has 
debilitating consequences including motor impairments, speech impairments and 
memory loss, and can be fatal. The molecular mechanisms underlying extreme oxygen 
deprivation are not well understood. Here we describe a novel role for neuropeptide 
signaling in regulating survival of the nematode Caenorhabditis elegans under anoxic 
conditions. We find that loss of neuropeptide signaling protects worms from extended 
anoxia and it does not rely on known pathways in stress tolerance and longevity for this 
effect. Loss of genes regulating cellular energy homeostasis and membrane lipid 
synthesis suppresses neuropeptide-mediated protection, indicating an important role for 
metabolism in surviving extended anoxia. Additionally, the nervous system is necessary 
for the secretion of neuropeptides mediating this phenotype, and a screen of 
neuropeptide genes identified nlp-40 as a partial regulator of anoxic survival. Together, 
these data highlight a potential cell non-autonomous regulation of survival against 
extreme environmental stress. 
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Introduction 
Molecular oxygen is essential to the function and survival of multicellular 
organisms. It is the final electron-acceptor of the electron transport chain during 
mitochondrial oxidative phosphorylation, and is thus critical for producing the vast 
majority of ATP to fuel cellular functions (Rich, 2003). Even short periods of oxygen 
deprivation cause cell and organismal damage and death. While all organs are sensitive 
to changes in oxygen, the brain is unique in that it consumes the most (20% of total 
oxygen consumed) of any organ (Erecińska and Silver, 2001). It is, therefore, also the 
most sensitive to oxygen deprivation. There are many injuries and disorders where the 
brain experiences decreased oxygen supply, such as sudden cardiac arrest, ischemic 
stroke, strangulation, choking, carbon monoxide poisoning and seizures (Hopkins and 
Haaland, 2004). Birth-related injuries lead to hypoxic-ischemic encephalopathy in 
newborn infants (Volpe, 2001). Depending on the age at injury and the area of brain 
affected, there are wide-ranging and severe consequences of oxygen deprivation such 
as changes in mood and personality, loss of motor function or speech, memory loss and 
cognitive impairment (Yogaratnam et al., 2013). Understanding the genetic and 
molecular regulation of cellular response to oxygen deprivation can help design 
therapies and drugs to combat its devastating effects. 
C. elegans, the soil-living nematode, is a great model to study oxygen 
deprivation, and has been used as such across its lifespan (Van Voorhies and Ward, 
2000; Padilla et al., 2002; Scott et al., 2002; Peña et al., 2016). It is a relatively simple, 
1mm long organism with 959 somatic cells and 302 neurons (www.wormbook.org). It 
has a short life cycle (it grows from egg to adult in 3 days and lives for 2-3 weeks), feeds 
on bacteria and is transparent, all of which allow for ease of experimental manipulation. 
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Importantly, its neuronal connectivity is completely mapped, its genome shares 
significant homology with humans and is completely sequenced, and many molecular 
pathways are identical between C. elegans and mammals.  
Since it lives in soil, C. elegans generally prefers lower environmental oxygen (5-
12% O2) (Gray et al., 2004). Interestingly, it has distinct responses to moderate and 
severe oxygen deprivation (Padilla et al., 2002). Worms can survive, develop and 
reproduce under low oxygen, hypoxic conditions (0.5-1% oxygen) while decreasing their 
oxygen consumption and locomotion (Jiang et al., 2001). However, under extreme 
oxygen deprivation or anoxia (<0.1% oxygen), worms become hypometabolic, and 
suspend development, feeding and reproduction (Van Voorhies and Ward, 2000; Padilla 
et al., 2002; Nystul et al., 2003). Depending on growth conditions, they can survive in 
this ‘suspended animation’ state for long periods (a few days), but eventually die if 
oxygen is not reintroduced. Upon reoxygenation, they resume normal activity including 
reproduction. While the hypoxic response in C. elegans is extensively studied and 
depends on the canonical hypoxia induced factor (hif-1) pathway, the anoxic response is 
hif-1-independent and is less well understood (Padilla et al., 2002).  
Studies in the past decade have shed light on some features of the worm 
response to anoxia. Loss of function in daf-2, the worm homolog of the insulin-like 
growth factor 1 (IGF1) receptor, protects worms from anoxia, suggesting a role for 
insulin signaling in this response (Scott et al., 2002). This protective effect of daf-2 loss 
of function requires activity of its downstream transcription factor daf-16, the worm 
homolog of the forkhead box protein O (FOXO). Similarly, loss of function mutation in 
nsy-1, a MAP3K, also protects worms from anoxia (Hayakawa et al., 2011). Mutations 
the AMPK pathway (LaRue and Padilla, 2011) and the ceramide synthesis pathway 
(Menuz et al., 2009) make worms hyper sensitvie to anoxia, suggesting a role for 
59	
	
metabolism in the worm anoxic response. Indeed, ATP levels decrease during anoxia, 
and increase upon re-exposure to air (Van Voorhies and Ward, 2000; Padilla et al., 
2002).  
Previous work from our lab shows that the BAG sensory neuron, which detects 
downshifts in environmental oxygen, makes worms sensitive to anoxia. In worms where 
the BAG neuron is genetically ablated, anoxic survival is significantly higher than wild 
type worms (Flibotte et al., 2014). Similarly, we found that in the absence of 
neuropeptide synthesis and secretion, worms survive anoxia significantly better (Flibotte 
et al., 2014). However, neuropeptide signaling is not required in BAG neurons for this 
effect.  These experiments utilized a temperature sensitive allele of egl-3 and were 
conducted at 25 degrees Celsius to enhance egl-3 loss of function. At this higher 
temperature, the temperature sensitive egl-3 mutant continued to be protective against 
anoxic insult. Restoring neuropeptide synthesis specifically in BAG neurons in a 
neuropeptide synthesis-deficient background did not rescue the survival benefit 
conferred by loss of egl-3 mediated neuropeptide signaling. One interpretations of this 
result is that there was not sufficient rescue of egl-3 in the BAG neurons. Alternatively, 
these data suggest that neuropeptide signaling is not required in BAG neurons, is not 
directly related to oxygen sensing, and perhaps works in a parallel, cell non-autonomous 
fashion to regulate worm response to anoxia.  
How, then, does neuropeptide signaling regulate worm survival against anoxia? 
We hypothesize that discrete neuropeptides are secreted by neurons and lead to 
inhibition of stress-resistance and longevity pathways to make developing wild type 
worms specifically vulnerable to anoxia. To test this hypothesis, we sought to answer the 
following questions: Is the regulation of anoxia by neuropeptides specific to this stress? 
Which tissues do neuropeptides act in? What known mechanisms in stress resistance 
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and longevity, if any, impinge on the regulation by neuropeptides? Which specific 
neuropeptides are involved in this anoxic response? How does exposure to anoxic 
stress impact worm lifespan? We chose the L4 larval stage of development to address 
these questions, since it is known to be sensitive to anoxia (Padilla et al., 2002; Flibotte 
et al., 2014), and can approximate hypoxic ischemic encephalopathy experienced at 
birth by newborn infants. Our goal is to expand our understanding of the C. elegans 
response to anoxia by focusing on the neuropeptide regulation of this stress to address 
these questions. 
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Results 
Loss of neuropeptide signaling protects against anoxic stress in developing C. 
elegans 
We previously found that loss of function mutations in egl-3 and unc-31 protected 
worms against anoxia (Flibotte et al., 2014). EGL-3 is a proprotein convertase required 
for maturation of peptide hormones (Thacker and Rose, 2000). It cleaves larger 
proprotein peptides into smaller peptides with C-terminal basic residue(s). Loss of egl-3 
impedes synthesis of hormones, including neuropeptides. UNC-31 is a calcium-
dependent activator protein for secretion (CAPS). It is required for fusion and exocytosis 
of neuropeptide-containing dense core vesicles at presynaptic membranes (Speese et 
al., 2007). Wild-type (N2) survival after anoxia is dependent on the duration of the insult: 
80-90% of N2 worms survive 24 hours of anoxia while only 30-50% survive 48 hours of 
anoxia (Van Voorhies and Ward, 2000; Padilla et al., 2002; Flibotte et al., 2014). As a 
result, we chose 48 hours of anoxic insult to measure changes in susceptibility to this 
stress. 
 
N2 egl-21
(n476)
0.0
0.5
1.0
M
ea
n 
su
rv
iv
al
 fr
ac
tio
n
+/
- S
EM
*
N2 unc-31
(e928)
egl-3 
(ok979)
0.0
0.5
1.0
M
ea
n 
su
rv
iv
al
 fr
ac
tio
n
+/
- S
EM
**
*
Figure 3.1. Survival of neuropeptide processing and secretion mutants at the L4 
stage after 48 hours of anoxia. For a) data were analyzed using one-Way ANOVA 
with Tukey’s test for multiple comparisons (n = 4 independent experiments). For b) 
data were analyzed using paired t-test (n = 6 independent experiments). *p < 0.05, **p 
< 0.01
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We confirmed these findings in egl-3 and unc-31 mutants, and also found that loss of 
egl-21 was protective against 48 hours of anoxia (Fig. 3.1a and b). EGL-21 is a 
carboxypeptidase that is required for maturation of neuropeptides. It removes the C-
terminal basic residue(s) from small peptides generated by EGL-3 (Jacob and Kaplan, 
2003). Thus, loss of function of multiple genes required for neuropeptide synthesis and 
secretion protect worms from anoxic stress. Interestingly, all three of these genes have 
human homologs, and play the same roles in peptide hormone synthesis and secretion 
(Thacker and Rose, 2000; Jacob and Kaplan, 2003; Speese et al., 2007).  
This protective effect was specific to the L4 stage of development, the final larval 
stage before worms enter adulthood. We found that 90-100% of young adult worms 
survived 48 hours of anoxia while 30-50% of L4 worms survived the same insult (Fig. 
3.2a). The L4 stage of worm development lasts upto 8 hours, during which worms 
undergo a variety of physiological changes. 
 
Given that developing worms respond to 48h anoxia differently than mature worms, we 
asked if worms in early L4 would be different from those in late L4 in their anoxic 
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Figure 3.2. Worms are sensitive to 48 hours of anoxia specifically at the L4 stage.  a) 
Survival of L4 vs young adult (L4 + 1day) N2 worms after 48 hours of anoxia (n = 4 
independent experiments). b) Survival of early L4 vs late L4 worms after 48 hours of 
anoxia, using the qIs56 [lag-2::GFP + unc-119(+)] reporter worm to define early and late L4 
based on tip cell maturation (n = 5 independent experiments). Data were analyzed using 
paired t-test. *p < 0.05
a b
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susceptibility. We used a reporter line qIs56 [(lag-2::GFP) + unc-119(+)] for distal tip cell 
maturation (Blelloch et al., 1999) to accurately distinguish early and late L4 worms, and 
subjected them to 48h anoxia. There was no significant difference in anoxic survival 
between the two sub-stages (Fig. 3.2b).   
In addition to O2 depletion, 8-12% CO2 is generated in the biobags used for these 
studies (per manufacturer). Work by others suggests that worms reduce pharyngeal 
pumping in response to high CO2 levels, and this is in part mediated by egl-21 and unc-
31 (Sharabi et al., 2014). In order to determine if the worms were responding to 
hypercarbia instead of anoxia, we placed L4-staged N2, egl-3 and unc-31 worms in a 
chamber with 20% O2 and 10% CO2. After 48 hours in this chamber, none of the lines 
had developmentally arrested (‘stunned’) or died as they do in the biobags. Rather, they 
had developed to adulthood, laid eggs and these eggs had hatched (data not shown). 
We also tested gcy-9 mutant worms, since GCY-9 is known to be necessary for sensing 
CO2, thereby regulating worm avoidance to the gas (Hallem et al., 2011). Loss of gcy-9, 
however, did not alter survival of worms after 48 hours of anoxia compared to N2 
animals (data not shown). Therefore, we concluded that the phenotype we studied was 
specific to anoxia. 
We also found that protection conferred by loss of neuropeptide signaling was 
specific to anoxic stress. Neuropeptide signaling mutants subjected to heat stress, UV 
stress or tunicamycin-induced ER stress did not survive any better than N2 worms (Fig. 
3.3).  
Together, these data show that developing (L4) C.elegans are sensitive to anoxic 
stress in a duration-dependent manner, and loss of function mutations in neuropeptide 
synthesis and secretion specifically confer a survival benefit against this stress. This 
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indicates that neuropeptide signaling makes worms vulnerable to extreme oxygen 
deprivation. 
 
 
Biogenic amines do not underlie unc-31-mediated anoxic survival 
 In C.elegans, dense-core vesicles are known to package biogenic amines in 
addition to peptides (Berendzen et al., 2016). We wondered if unc-31-mediated 
protection under anoxia was partially due to loss of biogenic amine signaling. There are 
four biogenic amines in C.elegans: serotonin, dopamine, tyramine and octopamine. 
These are synthesized by tryptophan hydroxylase (tph-1), tyrosine hydroxylase (cat-2), 
tyrosine decarboxylase (tdc-1) and tyramine β-hydroxylase (tbh-1) respectively. In order 
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Figure 3.3. Response of neuropeptide signaling mutants to different stresses. a) Survival of embryos after 
adult parents (n=16-25 animals) are irradiated with different doses of UV-B. b) Survival of L1 worms (n=40-160 
animals) irradiated with different doses of UV-B. c) Survival of L4 worms (n=50 animals) after 5h and 12h of 34C 
heat shock. Data were analyzed by Two-Way ANOVA with Tukey’s test for multiple comparisons. d-f) Survival of N2 
(d), unc-31 (e) and egl-3 (f) worms at L4 placed on NGM, DMSO (Vehicle) or Tunicamycin plates. Data are 
analyzed using the Mantel-Cox test for survival curve comparison. *p < 0.05, **p < 0.01, ***p < 0.001
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to test their contribution to anoxic survival via UNC-31, we measured survival of worms 
with loss of function mutations in each of these enzymes. We found that none of these 
mutants had a significant survival benefit compared to N2 (Fig. 3.4), suggesting that loss 
of unc-31 confers a survival benefit specifically due to loss of neuropeptide signaling. 
 
 
 
Neuropeptide synthesis in the nervous system is necessary for survival under 
anoxic stress 
 Reporter studies have shown that UNC-31 and EGL-21 are ubiquitously 
expressed in the nervous system and have little detectable expression in other tissues 
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Figure 3.4.  Survival of biogenic amine synthesis mutants at L4 after 48 hours of anoxia. N2 and 
unc-31 survival was compared against survival of a) tryptophan hydroxylase (tph-1), b) tyrosine 
decarboxylase (tdc-1), c) tyramine β-hydroxylase (tbh-1) and d) tyrosine hydroxylase (cat-2). Data were 
analyzed using one-way ANOVA with Tukey’s test for multiple comparisons (n = 3 independent 
experiments for all).
a b
c d
66	
	
(Jacob and Kaplan, 2003; Speese et al., 2007). Similarly, EGL-3 is broadly expressed in 
the nervous system, but there is evidence that it is also expressed in non-neuronal cells, 
such as the intestine (Hung et al., 2014). We wanted to know which tissue egl-3 loss 
was required in for its pro-survival effect under anoxic conditions. To this end, we 
generated worms expressing genomic egl-3 under either a pan-neuronal, intestinal or 
muscle-specific promoter into the egl-3 mutant background. These lines should be null 
for egl-3 in the whole animal except neurons, muscles and intestine, respectively. After 
subjecting these lines to anoxia, we found that intestinal and muscle expression of egl-3 
did not rescue the survival benefit seen in egl-3 null worms. However, neuronal 
expression of egl-3 rescued this survival benefit back to wild-type levels (Fig. 3.5a). We 
confirmed this finding using pan-neuronal knockdown of egl-3 using RNAi using a worm 
strain sensitized for neuronal RNAi (Firnhaber and Hammarlund, 2013). Compared to 
worms raised on empty vector (EV) bacteria, those raised on pan-neuronal RNAi against 
egl-3 survived anoxia significantly better (Fig. 3.5b). This indicates that loss of egl-3 in 
neurons is necessary to confer survival under anoxia, and that neuropeptides 
synthesized in the nervous system make worms susceptible to anoxic stress. These 
data are also consistent with the expression pattern of unc-31 and egl-21.  
 In order to determine which neuronal subpopulations were necessary for the egl-
3 loss of function phenotype, we similarly conducted RNAi experiments to knock down 
egl-3 in glutamatergic, cholinergic, GABAergic and dopaminergic cells specifically. To do 
this, we obtained worms that were optimized for dsRNA uptake in the specific neuronal 
subtypes (Firnhaber and Hammarlund, 2013). We found that glutamatergic and 
GABAergic neurons do mediate this effect, because we saw significantly higher survival 
upon egl-3 knockdown in these tissues compared to the same worms fed EV bacteria 
after 54h anoxia (Fig 3.5b). In preliminary experiments (n=2) there was no significant 
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difference between EV and egl-3 RNAi groups in cholinergic and dopaminergic neurons 
after 72h anoxia. These experiments were done under higher anoxia durations (54h and 
72h) since we found that all these lines survived 48h of anoxia very well, making those 
data difficult to interpret. Together, these RNAi experiments tell us that loss of egl-3 
function in multiple neuronal subtypes, including glutamatergic and GABAergic neurons, 
accounts for the survival phenotype of egl-3 null worms. 
 
 
 
Known stress-resistance/longevity pathways do not regulate neuropeptide-
mediated survival under anoxia  
 We wanted to understand the mechanism by which neuropeptide signaling 
affects survival under anoxia. Do genes and pathways previously shown to regulate 
stress responses also underlie neuropeptide-mediated anoxic susceptibility?  
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Figure 3.5.  Neuron-specific regulation of egl-3 mediated survival after anoxia. a) Survival of worm lines 
expressing genomic EGL-3 in neurons (PF2B3.3), body wall muscle (Pmyo-3) and intestine (Pges-1) in an egl-3 null 
background (n = 3 independent experiments). Data were analyzed using one-way ANOVA with Tukey’s test for 
multiple comparisons. b) Survival of lines fed EV (TU3311) or egl-3 RNAi bacteria for at least 2 generations. Each 
line expresses either SID-1 or RDE-1 to allow RNAi mediated egl-3 knockdown in neuronal subtypes. Pan-neuronal 
= TU3311 (Punc-119::sid-1) (n=6), glutamatergic = XE1582 (Peat-4::rde-1) (n=3), GABAergic = XE1375 
(Punc-47::rde-1;Punc-47::mCherry) (n=3), cholinergic = XE1581 (Punc-17::rde-1) (n=2), dopaminergic = XE1474 
(Pdat-1::rde-1) (n=2). Data were analyzed using paired t-test between EV and egl-3 RNAi for each line. *p < 0.05, 
**p < 0.01
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To test this, we interrogated loss of function mutations in a variety of such genes in the 
unc-31 and/or egl-3 background. We tested the following genes due to their described 
role in anoxia, hypoxia or general stress resistance/longevity: (i) daf-16 (Scott et al., 
2002; Mendenhall et al., 2006a), (ii) hif-1 (Zhang et al., 2009), (iii) hsf-1 (Hsu et al., 
2003), (iv) skn-1 (Ghose et al., 2013), (v) nsy-1 (Hayakawa et al., 2011). Briefly, we 
made double mutants between the mutant gene of interest (i-v above) and unc-31/egl-3 
mutants, and subjected them to anoxia. Our reasoning was that if increased anoxic 
survival of unc-31/egl-3 mutants was due to the activity of any one of the genes i-v, then 
loss of that gene in the unc-31/egl-3 mutant background would reverse the survival 
benefit. 
 We found no significant difference in survival between unc-31 or egl-3 mutant 
strains and the respective double mutant strains (Fig. 3.6). Thus, none of these genes 
were unable to rescue survival benefit conferred by loss of unc-31 or egl-3. These data 
indicate that either these genes act in parallel to neuropeptide signaling, or that 
neuropeptide-mediated regulation of anoxia requires the activity of an untested or novel 
cellular factor and does not involve most known stress resistance or longevity promoting 
pathways.  
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Figure 3.6. Survey of canonical stress-resistance and longevity promoting genes in 
regulating neuropeptde-mediated anoxia sensitivity. Survival of the following double 
mutants containing egl-3 or unc-31 was compared with egl-3 or unc-31 alone. a) 
daf-16;unc-31 b) daf-16;egl-3 c) hif-1;unc-31 d) hsf-1;unc-31 e) skn-1;egl-3 f) nsy-1;unc-31. 
(n = 3 independent experiments for b), n = 4 for rest). Data were analyzed using one-way 
ANOVA with Tukey’s test for multiple comparisons. 
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Genes involved in cellular metabolism suppress survival benefit induced by loss 
of neuropeptide signaling 
Since worms enter a hypometabolic, suspended animation state in order to 
survive long term anoxia, we wondered if disrupting genes involved in regulating cellular 
metabolism would affect neuropeptide-mediated sensitivity to anoxic stress. AMP-
associated kinase (AMPK) is the master cellular sensor of a decrease in the ATP/AMP 
ratio. When cellular ATP levels decline, AMPK is activated by phosporylation, and in turn 
it promotes anabolic pathways and restricts catabolic pathways in the cell. Studies have 
shown that ATP levels decrease during worm anoxia (Van Voorhies and Ward, 2000; 
Padilla et al., 2002), and that loss of the worm AMPK, aak-2, also makes worms 
vulnerable to anoxia (LaRue and Padilla, 2011). Previous studies have also implicated 
the short chain (C20-22) ceramide syntase HYL-2 in regulating C. elegans response to 
anoxia (Menuz et al., 2009). Ceramides are essential components of the lipid bilayer, 
and are involved in regulating metabolic homeostasis (Bikman and Summers, 2011). 
Loss of function mutations in hyl-2 made worms extremely sensitive to anoxia, and lack 
of hyl-2 signficantly decreased the survival benefit conferred by mutant daf-2 (Menuz et 
al., 2009).  We decided to test these two genes to assess their involvement in the 
neuropeptide-mediated survival phenotype we observe in developing worms.  
First, we confirmed that loss of hyl-2 and aak-2 renders worms hypersensitive to 
our anoxic conditions. Next, we studied the genetic doubles hyl-2;unc-31, hyl-2;egl-3, 
and aak-2;unc-31. In contrast to other stress-resistance genes discussed in the previous 
section, loss of hyl-2 and aak-2 completely suppressed the survival benefit in the egl-
3/unc-31 mutant background (Figure 3.7a-c and 3.7e). We confirmed the effect of hyl-2 
in two different ways: (i) we tested two different loss of function mutations and obtained 
the same result (Fig. 3.7a and 3.7b), and (ii) we outcrossed hyl-2 from the unc-31;hyl-2 
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double mutant to directly test hyl-2 involvement in survival suppression (Fig. 7d). 
Outcrossing hyl-2 reversed the sensitivity to anoxia seen in the double mutant. In fact, 
the outcrossed strain had similar survival as the unc-31 mutant alone, confirming that 
hyl-2 was necessary for suppression of the unc-31 phenotype. These data indicate that 
cellular pathways regulating energy metabolism in the cell are critical to surviving anoxic 
stress, and that neuropeptide signaling likely acts downstream of these metabolic factors 
in regulating anoxia response.
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Figure 3.7. Anoxia resistance of egl-3 and unc-31 mutants is suppressed by loss of the ceramide 
synthase hyl-2 and the ATP/AMP sensor aak-2. All experiments were done with L4 animals under 48 hours 
anoxia. a) and b) Survival of two different mutant alleles of hyl-2 in the unc-31 mutant background (n = 8 and 3 
independent experiments respectively). c) Survival of mutant hyl-2 in mutant egl-3 background (n=4). d) Survival 
of mutant unc-31 after outcrossing hyl-2 from the hyl-2;unc-31 strain tested in (a) (n=4). e) Survival of aak-2 
mutant in the unc-31 mutant background (n=3). Data were analyzed using one-way ANOVA with Tukey’s test for 
multiple comparisons.
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The neuropeptide nlp-40 partly regulates C. elegans response to anoxia 
 Loss of egl-3, egl-21 and unc-31 should lead to an inhibition of all neuropeptide 
synthesis in the worm. We predicted that the anoxic survival benefit in these mutant 
worms is mediated by either a single neuropeptide or a group of neuropeptides. There is 
a rich body of literature that implicates single neuropeptides in regulating complex 
behaviors and pathways in worms (Nelson et al., 2013; Cheong et al., 2015; Chen et al., 
2016; Shao et al., 2016; Turek et al., 2016). Therefore, we set out to find putative 
neuropeptide(s) that may underlie the effect of egl-3/egl-21/unc-31 loss of function under 
anoxic conditions. There are 113 genes encoding over 250 distinct neuropeptides in 
C.elegans, most of which do not have clearly defined functions (www.wormbook.org). 
These neuropeptide genes are broadly divided into three groups: insulins (ins), FMRF-
like peptides (flp) and non-insulin/non-FMRF like peptides (nlp).  
The first class of neuropeptides we addressed was the insulins, because (i) loss 
of function in the insulin receptor daf-2 is also protective against anoxia and this 
protection is dependent on its downstream transcription factor daf-16 (Scott et al., 2002), 
and (ii) EGL-3 is known to process ins propeptides to generate their mature, active forms 
(Hung et al., 2014). However, the unc-31;daf-16 and egl-3;daf-16 double mutants have 
similar survival compared to unc-31 and egl-3 mutants alone (Fig. 3.6a and 3.6b) 
suggesting that the unc31/egl-3 effect on anoxia is independent of the DAF-2/DAF-16 
pathway. This allowed us to rule out the ins class of neuropeptides, and focus our 
search to flp’s and nlp’s. We tested survival of almost all available deletion mutants of 
flp’s (29 of 31 total flp’s) and nlp’s (36 of 42 total nlp’s) after 48 hours anoxia (Fig. 3.8a 
and 3.8b) in order to find mutants that mimicked the survival benefit seen in unc-31 loss 
of function worms.  
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 For our initial screen, we tested each mutant 2 independent times, with 3 
technical replicates each time. We had to reconcile the number of independent 
experiments we could carry out here because of the need to balance two competing 
issues – getting through the large screen of available mutants, and testing them 
thoroughly to avoid the substantial biological variability that is a constant feature of this 
anoxia assay. As expected, we did encounter a large amount of biologic variability in 
these experiments, making candidate identification challenging. Ultimately, we decided 
to narrow down an initial list of mutants that had an average survival greater than 50% 
across these 6 observations. The only exception was nlp-15, which was included in the 
candidate list because it had very high survival in one of the two experiments. This left 
us with 8 flp’s and 9 nlp’s for the secondary screen. One of the strains we tested had a 
very large deletion that removed many hundreds of genes (VC30122, which spanned 
nlp-25, nlp-26 and nlp-42). Because of this, we had 15 strains encompassing the 17 total 
mutations after our initial screen.  
To narrow down these candidates further, we employed three different tests – (i) 
repeat the experiment for each candidate >3-4 more times, (ii) backcross each line to N2 
at least 2X to remove mutations in the background genotype and (iii) rescue the deleted 
region in each mutant by injecting a wild-type copy of the gene. We were able to repeat 
the experiment in 11 of 14 strains, backcross 11 of 14 strains and rescue 7 of 14 strains. 
For most lines, repeating the experiment many times dropped the average survival to 
well below 50%, suggesting a high false-positive rate in our initial screen. Additionally, 
we noticed that backcrossing the lines led to high variability in the data. One line that 
had high survival (flp-3), had to be excluded because backcrossing it reduced its survival 
to N2 levels, and fosmid rescue did not reduce its high survival. This indicated that, at 
least for this line, background genotype led to a false positive hit in the initial screen. 
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Since we did not backcross all the lines before initially testing them, it is possible that by 
the same rationale, we may have missed potential hits due to background genetic 
contamination. Despite this limited approach, one of the candidates, nlp-40, was able to 
pass all three tests of the secondary screen (Fig. 3.8c and 3.8d). However, nlp-40 
mutant survival hovers around 50-60% despite backcrossing, suggesting that it is only 
partially responsible for the anoxia survival phenotype of unc-31. It is likely that more 
than one neuropeptide regulates anoxic survival in C. elegans. 
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Figure 3.8. Screen for flp and nlp neuropeptides regulating survival under anoxia. a) Survival of 31 strains 
containing deletions of individual flp’s after 48h anoxia (n = 2 independent experiments). b) Survival of 33 strains 
comprising 36 deletions of individual nlp’s after 48h anoxia (n=2). Strains highlighted in the orange box in (a) and 
(b) were selected as candidates for further screening. c) Survival of candidate flp’s and nlp’s before and after 2X 
backcrossing to N2 (n=3-9). d) Survival of candidate flp’s and nlp’s before and after rescue with a fosmid or a 
PCR fragment containing the genomic locus (n=3-5). Data were analyzed by a two-tailed paired t-test for each 
flp/nlp. Data appear as ‘boxes’ instead of ‘lines’ if the experiment was conducted more than 3 times.  *p <0.05.
75	
	
Discussion  
C. elegans employs neuropeptides to regulate a wide range of physiological 
functions. They are involved in many behaviors such as, among others, locomotion 
(Hums et al., 2016), sleep (Nelson et al., 2013), feeding (Cheong et al., 2015), egg-
laying (Ringstad and Horvitz, 2008), mechanosensation (Hu et al., 2011) and 
chemosensation (Cohen et al., 2009). Genes encoding neuropeptides are expressed 
widely throughout the nervous system but are also found in non-neuronal tissue such as 
intestine, the vulval hypodermis and the gonads. They act both locally at synapses and 
over long distances as hormones to coordinate these behaviors within and between 
tissues (Rabinowitch et al., 2016).  
Here, we establish a novel role for neuropeptides in regulating a specific stress – 
extreme oxygen deprivation – in developing C. elegans. We confirm and expand on 
previous work (Flibotte et al., 2014) to demonstrate that loss of neuropeptide synthesis 
by egl-3 and egl-21, as well as loss of neuropeptide secretion by unc-31, lead to 
increased survival when exposed to anoxia. This protective effect of neuropeptide loss is 
specific to anoxic stress (Fig. 3.3). Hence, neuropeptide signaling makes worms 
vulnerable to anoxic insult in particular. We found that neuropeptide synthesis is 
necessary in the nervous system for this effect (Fig.3.5), is independent of insulin 
signaling and does not rely on established stress-resistance and longevity-promoting 
genes (Fig. 3.6).  
 
Cell autonomous vs cell non-autonomous actions of neuropeptides 
The insulin signaling pathway is known to regulate stress-resistance and 
longevity in worms, flies and even mammals (Holzenberger et al., 2002; Broughton et 
al., 2005; Henis-Korenblit et al., 2010). DAF-2 is the insulin/insulin-like growth factor 
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receptor homolog in worms. Insulin-like peptides can bind and activate DAF-2, which 
initiates an intracellular phosphorylation signaling cascade ultimately leading to the 
sequestration of the transcription factor DAF-16 (worm homolog of FOXO) to the cytosol, 
thus preventing transcription of DAF-16 targets. DAF-2 loss of function leads to 
increased lifespan and increased tolerance to many stressors including heat, UV 
radiation, oxidative stress, hypoxia and anoxia (G J Lithgow, 1995; Murakami and 
Johnson, 1996; Honda and Honda, 1999; Scott et al., 2002; Mendenhall et al., 2006b). 
We show here that neuropeptide-mediated regulation of survival against anoxia is 
independent of the DAF-2/DAF-16 pathway. DAF-2 expression in neurons and muscles, 
but not intestines, rescues the extreme hypoxic (<0.3%) survival benefit of daf-2 mutant 
worms (Scott et al., 2002). Our data shows that neuropeptide signaling is necessary in 
neurons and acts in a parallel pathway to DAF-2/DAF-16, which suggests that the daf-2 
mediated survival benefit must be due to its expression in muscles. If the DAF-2/DAF-16 
pathway acts in non-neuronal tissues for regulating response to anoxia, it would argue 
for two separate, cell autonomous regulatory pathways influencing survival under anoxic 
stress. Future studies need to address tissue-specific regulation of anoxia by DAF-
2/DAF-16.  
Neuropeptide-mediated regulation of behaviors can also occur in a cell non-
autonomous fashion (Shao et al., 2016). Here, we find that for inducing sensitivity to 
anoxia, neuropeptide synthesis is necessary in neurons. The BAG sensory neurons in 
worms are responsible for detecting a decrease in environmental oxygen. However, 
surviving anoxic stress during development does not require neuropeptide signaling from 
BAG neurons (Flibotte et al., 2014), since egl-3 null worms with BAG-specific rescue of 
egl-3 continue to survive anoxia similar to egl-3 null worms. The neuropeptide flp-17 is 
primarily expressed in BAG neurons (Ringstad and Horvitz, 2008). In this study, we find 
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that loss of flp-17 does not protect L4 worms from anoxia (Fig.3.8a), further suggesting 
that neuropeptide-mediated regulation of survival under anoxic stress acts in non-BAG 
neurons. However, where the neuropeptides act remains to be determined.  
We describe nlp-40 as a partial regulator of the worm response to anoxia. The 
only published paper about nlp-40 describes its expression to be limited to the intestine 
(Wang et al., 2013), which does not agree with our results of neuropeptides in anoxic 
regulation. There are two ways to reconcile the differences in our findings: first, it could 
be that the nlp-40 mediated regulation of anoxic survival is independent of egl-3 and 
unc-31. Perhaps nlp-40 is processed by a proprotein convertase other than egl-3. There 
are 5 different proprotein convertases in C. elegans, and their expression and function 
remain to be fully understood. Second, it is likely that the reporter construct used in the 
study by Sieburth et al did not fully capture nlp-40 expression. Finally, the putative 
receptor for nlp-40 is aex-2 (Wang et al., 2013), which is thought to be expressed in 
GABAergic neurons, and loss of function mutants of aex-2 are smaller in size and have 
a pale appearance similar to nlp-40 mutants. Studying aex-2 mutants under anoxia may 
also provide insight into the mechanism of action and cell-type specificity of nlp-40 
function. Understanding which cells neuropeptides act on will provide insight into the 
mechanism by which peptides induce anoxic sensitivity in worms, and elucidate their 
local vs. long range actions for modulating physiological responses. 
 
Metabolism and anoxia 
Worms enter a hypometabolic, ‘suspended animation’ state when exposed to 
anoxia, wherein they dramatically reduce their metabolic rate (Van Voorhies and Ward, 
2000; Padilla et al., 2002). In the absence of oxygen, energy consumption occurs via 
breakdown of carbohydrates instead of fats. In fact, carbohydrate stores are depleted by 
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two-thirds in adult animals exposed to 24 hours of anoxia (Föll et al., 1999), and worms 
mutant for the glycolytic enzyme glyceraldehyde-3 phosphate dehydrogenase (gpd-2 
and gpd-3), are sensitive to anoxia (Mendenhall et al., 2006a). ATP/AMP levels are 
reduced in embryos exposed to anoxia (Padilla et al., 2002). Consistent with this, worms 
mutant for AMPK (aak-2), the master sensor of ATP/AMP, are also sensitive to anoxia, 
as shown previously in adult worms (LaRue and Padilla, 2011) and here in L4 worms. 
Further, a lipid synthesis promoting transcription factor, SREBP1 is required for fatty acid 
accumulation (which requires oxygen) after anoxia (Taghibiglou et al., 2009b). 
Ceramides are important components of the lipid bilayer in cells, and HYL-2, a short 
chain ceramide synthase, is essential for surviving anoxia (Menuz et al., 2009), 
suggesting a role for lipids before anoxia as well. Additionally, diet and nutrition also 
contribute to anoxic survival, as worms fed a higher carbohydrate food source survive 
long-term anoxia better (LaRue and Padilla, 2011). Mutants for nlp-40 are shown to 
deficient in their defacation cycle (Wang et al., 2013) and have a pale appearance, 
presumably due to intestinal swelling and altered fat deposits. Together, these 
observations suggest an important, but incompletely understood contribution of 
metabolism in regulating survival from long-term anoxia exposure. 
We find that survival promoted by loss of neuropeptide signaling is completely 
suppressed by loss of the ATP/AMP sensor AMPK as well as the short-chain ceramide 
synthase HYL-2. AMPK and ceramide synthases are important modulators of cellular 
metabolism and cell membrane integrity. What does the lethality of neuropeptide 
mutant;aak-2 and neuropeptide mutant;hyl-2 tell us about the role of cellular metabolism 
in anoxia? It is interesting to note that hyl-2 loss of function also suppresses the survival 
benefit induced by daf-2 in L4 and young adult worms (Menuz et al., 2009; Garcia et al., 
2015). Similarly, loss of aak-2 significantly reduces the survival benefit of daf-2 animals 
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(LaRue and Padilla, 2011). Our work here shows that EGL-3/UNC-31 mediated 
neuropeptide signaling and DAF-2/DAF-16 mediated insulin signaling are independent 
pathways in regulating anoxia survival. AMPK and HYL-2 can thus suppress the effects 
of two independent pathways involved in anoxia. These two genes may thus act as 
master regulators of energy metabolism in the cell acting upstream of these two 
pathways, further implying that cellular energy is critical to surviving anoxia.  
 
Enhancing understanding of neuropeptides and anoxia 
While this work reveals a new role for neuropeptide signaling, it also opens up 
many potential directions for future study. First, we don’t know why neuropeptide 
signaling would make worms sensitive to anoxia. It would be beneficial to understand 
how much energy neuropeptide synthesis and secretion requires. Given the important 
role of hypometabolism to surviving anoxia, perhaps the cell cannot afford the energy 
consumed by neuropeptide signaling. Second, we don’t know when neuropeptide 
signaling is necessary for inducing anoxic sensitivity in worms. Is neuropeptide signaling 
needed before worms are exposed to anoxia or during the recovery from anoxia? Given 
that many N2 worms already appear dead immediately after re-exposure to oxygen, we 
would hypothesize that neuropeptide signaling is at least in part necessary before and/or 
during exposure to anoxia. The egl-3, egl-21 and unc-31 mutants we use have loss of 
function in these genes throughout their life. In order to address this timing issue, 
constitutive mutants that lose gene function at different stages of life, and at different 
time points before, during and after anoxia will need to be generated. Third, while we 
rule out many canonical stress resistance pathways in contributing to anoxia, we do not 
know how neuropeptides lead to anoxic sensitivity. One pathway that remains 
unexplored in this context is the unfolded protein response (UPR) pathway, which is 
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implicated in different stress responses, including anoxia (Kaufman and Crowder, 2015). 
Neuropeptide signaling may play a role in regulating the UPR, thus regulating the 
response to anoxia.  
 
Conclusion 
This work establishes a novel role for neuropeptide signaling in C. elegans 
response to extreme oxygen deprivation, thereby expanding on genetic and molecular 
regulation of anoxic stress in worms. It suggests that cell non-autonomous regulation 
may play a key role of the response to anoxia that is independent of known stress 
resistance pathways in worms. 
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Methods 
Worm husbandry 
 C. elegans were cultivated at 20 degrees Celsius on nematode growth medium 
(NGM) agar surface, unless otherwise stated. NGM plates were seeded with a lawn of 
the E. coli strain OP50 as the food source, except in RNAi experiments.   
 
Worm Strains 
Strains used in this study are listed in Table 3.1. Double mutants were made 
using standard genetic techniques. Mutations were confirmed by PCR genotyping, and 
the primers used are also listed in Table 3.1.  
 
Anoxia assay 
Worms were synchronized by hypochlorite treatment and eggs were placed on 
fresh plates. For each experiment, 30-50 synchronized L4 animals from each genotype 
were placed on three fresh plates. Each plate was placed in a separate anerobic biobag 
(Becton Dickson, catalog # 261216) along with appropriate co-bagged controls. The 
bags were sealed and an anoxic environment (<0.1% O2) was generated by palladium 
catalyst mediated consumption of ambient oxygen in the bag (per manufacturer 
instructions). A resazurin indicator was included in each bag to confirm oxygen 
deprivation. Unless otherwise stated, worms were placed under anoxia for 48h, after 
which the bags were opened, and the resazurin indicator confirmed reintroduction of 
ambient oxygen in the bag. Anoxia exposure was also confirmed by ‘stunned’ phenotype 
of worms once the bags were opened ((Padilla et al., 2002; Flibotte et al., 2014)). Any 
bags that failed to achieve anoxia according to the indicator and/or due to the absence 
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of ‘stunning’ were excluded from the experiment. Animals were allowed to recover for 
24h after anoxia, after which dead and alive animals were manually scored. Animals 
were considered alive if they were moving, pumping their pharynx and/or responded to 
light touch. Each experiment thus had three technical replicates (3 bags), and 
experiments were generally repeated 3-6 times. The average survival fraction across 
experiments was reported. 
 
Heat shock assay 
 Synchronized L4 worms were picked onto fresh plates, sealed with parafilm and 
placed in a plastic bag submerged in a 34 degree Celsius water bath. Individual plates 
were removed after 5 hours and 12 hours to manually score living/dead animals and 
promptly returned to the water bath. Animals were scored alive if they were moving, 
pumping their pharynx and/or responded to light touch. 
 
ER stress assay 
 NGM plates were supplemented with 5mg/mL tunicamycin or equivalent DMSO 
vehicle (0.05%) and seeded with OP50 bacteria. Synchronized L4 worms raised on 
regular OP50 plates were placed on vehicle or tunicamycin plates and lifespan of worms 
on either plate was determined by scoring live/dead animals daily.  
 
UV stress assay 
To determine ‘germ cell’ survival, young adult animals were irradiated with 0, 80 
and 120 kJ/m2 UV-B and allowed to recover for 24h. Survival of the progeny (eggs laid 
for ~3 hrs) of the irradiated adults was then determined by counting dead and alive eggs. 
Average results across two independent experiments are presented. In each 
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experiment, survival on four replicate plates was determined (the offspring of 16-25 
irradiated animals). The xpa-1 mutant, necessary for nucleotide excision repair, was 
included as a positive control to demonstrate UV toxicity. 
Larval survival was determined by irradiating L1 larvae and scoring the 
percentage of animals that arrested/died or survived (developed into L4/adult) 48 hours 
later. Average results across two independent experiments are presented. In each 
experiment, survival of three replicate plates, each containing between 40 – 160 L1 
larvae, was determined. The xpa-1 (ok698) mutant was included as a positive control 
(Lans et al., 2010). 
 
Hypercarbia assay 
 Carbon dioxide was introduced into a sealed chamber fitted with a CO2 controller 
(ProCO2 from BioSpherix, Inc) until its concentration was 10% of room air, as measured 
by a CO2 sensor in the chamber. A separate sensor measured O2 concentration, which 
was 18% of room air. Synchronized L4 worms were placed in this chamber for 48 hours, 
after which they were removed and assessed for a ‘stunned’ phenotype and survival. 
 
RNAi experiments 
 NGM plates were seeded with E. coli expressing empty vector (L4440) or egl-3 
RNAi-encoding (C51E3.7) plasmids in order to perform feeding RNAi experiments. We 
tested worm strains sensitized to import dsRNA from the bacterial source, and induce 
RNAi against the target gene in either all neurons or specific subsets of neurons to 
achieve cell-type specific knockdown of egl-3. The strains used were: TU3311 (pan-
neuronal knockdown), XE1581 (cholingergic neuron knockdown), XE1582 
(glutamatergic neuron knockdown), XE1375 (GABAergic neuron knockdown) and 
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XE1474 (dopaminergic neuron knockdown). Worms from each of these strains were 
placed on either empty vector or egl-3 RNAi plates for 3-4 generations to ensure 
successful knockdown of egl-3. For anoxia experiments, worms were placed in anerobic 
biobags for 54h and allowed to recover for 24h before scoring survival. 
 
Neuropeptide screen 
 We assembled a list of all nlp’s and flp’s (wormbook.org) and interrogated 
Wormbase (wormbase.org) to identify mutants that were putative null. This list of 
neuropeptide mutants was obtained from either the CGC or the Japanese Consortium. 
We posited that deletion mutants would have the most severe loss of function 
phenotype. Any flp or nlp that did not have a deletion mutant available was excluded 
from the screen. Using this criterion, we were able to test 29 of 31 total flps (all but flp-23 
and flp-32) and 36 of 42 total nlps (all but nlp-4, nlp-6, nlp-13, nlp-16, nlp-33 and nlp-39). 
For the initial screen, each strain was tested two independent times, each time with 
three bags and with co-bagged N2 and unc-31 worms. The average survival of each 
strain across these 6 bags was used to narrow candidates for the secondary screen. 
Any stain with >50% average survival was selected for secondary screening. In the 
secondary screen, strains were (i) tested in 3 additional independent experiments, (ii) 
backcrossed 2x to N2 and retested, and (iii) subjected to rescue experiments using 
available fosmid DNA for each mutant (Source Bioscience, Nottingham UK). Fosmids 
were injected at 160ng/uL along with pmyo-2::mCherry as a coinjection marker. For nlp-
40 rescue experiments, the genomic rescue line used (OJ949) was generously donated 
by Dr. Derek Sieburth (Wang et al., 2013).  
 
Statistics 
85	
	
Data were analyzed using Prism (GraphPad Software, La Jolla, CA). Significant 
differences between two groups were determined using paired Student’s t-test (two-
tailed). Significant differences within groups greater than two were determined using 
one-way ANOVA followed by Tukey’s test for multiple comparisons. Survival curves 
were analyzed using the log-rank (Mantel-Cox) test for significance. For all tests, the 
significance threshold was set to p < 0.05. 
 
 
 
Table 3.2: A list of worm strains used in this study, along with their genetic 
description and primers used for genotyping (where applicable) 
 
Strain gene(allele)/genotype PCR primers 
N2 wild-type, Bristol  
CB928 unc-31(e928)  
VC671 egl-3(ok979) 
Fwd Primer: agtccaactccattcatttgc 
Rev Primer (outer): aattccagaactaaggacacg 
Rev Primer (inner): atctctacggaagatgcacc 
VC461 egl-3(gk238) 
Fwd Primer: ccattggagaaagtggaagc 
Rev Primer (outer): aagccagtttgacttttcagc 
Rev Primer (inner): ttcccacggaactcgatgc 
KP2018 egl-21(n476)  
JK2868 qIs56[(lag-2::GFP) + unc-119(+)]  
MT14525 gcy-9(n4470)  
RB864 xpa-1(ok698)  
MT15434 tph-1(mg280)  
MT15620 cat-2(n4547)  
MT13113 tdc-1(n3419)  
MT9455 tbh-1(n3247)  
RK132 egl-3(ok979);PF2B23.3::egl-3  
RK133 egl-3(ok979);Pges-1::egl-3  
RK134 egl-3(ok979);Pmyo-3::egl-3  
TU3311 uIs60[unc-119p::YFP + unc-119p::sid-1]  
XE1582 
wpSi11[eat-4p::rde-
1::SL2::sid-1 + Cbr-unc-
119(+)]; eri-1(mg366); rde-
1(ne219); lin15(n744) 
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XE1375 
wpIs36[unc-47p::mCherry]; 
wpSi1[unc-47p::rde-
1::SL2::sid-1 + Cbr-unc-
119(+)]; eri-1(mg366); rde-
1(ne219); lin15(n744) 
 
XE1581 
wpSi10[unc-17p::rde-
1::SL2::sid-1 + Cbr-unc-
119(+)]; eri-1(mg366); rde-
1(ne219); lin15(n744) 
 
XE1474 
wpSi6[dat-1p::rde-1::SL2::sid-
1 + Cbr-unc-119(+)]; eri-
1(mg366); rde-1(ne219); 
lin15(n744) 
 
GR1307 daf-16(mgDf50) 
Fwd Primer: ctctctctgtttctccccgc 
Rev Primer (outer): acggacactgttcaactcgt 
Rev Primer (inner): gcgagagtagcgatgttgga 
ZG31 hif-1(ia4) 
Fwd Primer: gaatgccgcatgttccgatc 
Rev Primer (outer): cggagcagcaatacaagatg 
Rev Primer (inner): atggtgtcttcagtccatacc 
PS3551 hsf-1(sy441)  
FX03411 skn-1(tm3411)/nT1[qIs51] 
Fwd Primer (outer): ctccgaaatctggaacgcc 
Fwd Primer (inner): gagattccgaagagaggcg 
Rev Primer: caggacgtcaacagcagac 
FX0850 nsy-1(tm850) 
Fwd Primer: gcgattccaggaaatgcacg 
Rev Primer (outer): ctccgtatcacactgcttatgg 
Rev Primer (inner): tcaacaagtgccacgtcagc 
FX02031 hyl-2(tm2031) 
Fwd Primer (outer): cgtactaccatttgtataccg 
Fwd Primer (inner): tctcacttctggtctccgg 
Rev Primer: cgtcgtcgcaacatctcct 
RB1498 hyl-2(ok979) 
Fwd Primer (outer): cgtactaccatttgtataccg 
Fwd Primer (inner): tctcacttctggtctccgg 
Rev Primer: cgtcgtcgcaacatctcct 
RB754 aak-2(ok524) 
Fwd Primer: cccaatctgccaaatactgac 
Rev Primer (outer): cacgaccatacatcaacttcg 
Rev Primer (inner): cattgttctgctcatcgagc 
RK135 unc-31(e928); daf-16(mgDf50)  
RK136 egl-3(e928); daf-16(mgDf50)  
RK137 unc-31(e928); hif-1(ia4)  
RK138 unc-31(e928); hsf-1 (sy441)  
RK139 egl-3 (ok979); skn-1(tm3411)/nT1  
RK140 unc-31(e928); nsy-1(tm850)  
RK141 unc-31(e928); hyl-2(tm2031)  
RK142 unc-31(e928); hyl-2(ok979)  
RK143 egl-3(ok979); hyl-2(tm2031)  
RK144 unc-31(e928); aak-2(ok524)  
NY16 flp-1(yn4)  
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VC2591 flp-2(ok3351) 
Fwd Primer: gcggattgaatcgttttccg 
Rev Primer (outer): ttctcgatgcggaaagttgc 
Rev Primer (inner): tttcctcgtccttctcgcc 
RK145 flp-2(ok3351)  2X backcrossed 
Fwd Primer: gcggattgaatcgttttccg 
Rev Primer (outer): ttctcgatgcggaaagttgc 
Rev Primer (inner): tttcctcgtccttctcgcc 
VC2497 flp-3(ok3265) 
Fwd Primer: gccaaatggagcactgtcg 
Rev Primer (outer): tttggtagcgtcgggtagg 
Rev Primer (inner): aatgagatttggaaagctgc 
RK146 flp-3(ok3265)  2X backcrossed 
Fwd Primer: gccaaatggagcactgtcg 
Rev Primer (outer): tttggtagcgtcgggtagg 
Rev Primer (inner): aatgagatttggaaagctgc 
NY226 flp-4(yn35) 
Fwd Primer: cacatgccagtctgcctaca 
Rev Primer (outer): ttgttcggtcaagactcggc 
Rev Primer (inner): ttgagacagagacgtgacgc 
RK147 flp-4(yn35) 2X backcrossed 
Fwd Primer: cacatgccagtctgcctaca 
Rev Primer (outer): ttgttcggtcaagactcggc 
Rev Primer (inner): ttgagacagagacgtgacgc 
VC20382 flp-5(gk320541)  
VC2324 flp-6(ok3056)  
VC20593 flp-7(gk951274)  
NQ913 flp-7  
PT501 flp-8(pk360)  
RB2067 flp-9(ok2730)  
RB1989 flp-10(ok2624)  
FX02706 flp-11(tm2706)  
RB1863 flp-12(ok2409)  
NQ602 flp-13(tm2427)  
VC1957 flp-14(gk1055) 
Fwd Primer: aggaaaaccggcaagcctag 
Rev Primer (outer): 	cggcgccataataacatctgc 
Rev Primer (inner): cgcccctgtttcctacttct 
RK148 flp-14(gk1055) 2X backcrossed 
Fwd Primer: aggaaaaccggcaagcctag 
Rev Primer (outer): 	cggcgccataataacatctgc 
Rev Primer (inner): cgcccctgtttcctacttct 
VC30176 flp-15(gk960606)  
FX04829 flp-16(tm4829)  
MT15933 flp-17(n4894)  
AX1410 flp-18(db99)  
RB1902 flp-19(ok2460)  
PT505 flp-20(pk1596)  
RB982 flp-21(ok889)  
VC3465 flp-22(gk1201)/hT2  
VC1971 flp-24(gk3109) 
Fwd Primer (outer): ctaagcaggcatactacagg 
Fwd Primer (inner): aaccacgcaaaatattattcg 
Rev Primer: ttggcatgccgaaaaaaggg 
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RK149 flp-24(gk3109)  2X backcrossed 
Fwd Primer (outer): ctaagcaggcatactacagg 
Fwd Primer (inner): aaccacgcaaaatattattcg 
Rev Primer: ttggcatgccgaaaaaaggg 
VC1982 flp-25(gk1016) 
Fwd Primer: tttgacccaattcacttgacg 
Rev Primer (outer): cttgattggacattgcgcga 
Rev Primer (inner): gcactccttttttgcttcgg 
RK150 flp-25(gk1016)  2X backcrossed 
Fwd Primer: tttgacccaattcacttgacg 
Rev Primer (outer): cttgattggacattgcgcga 
Rev Primer (inner): gcactccttttttgcttcgg 
VC3017 flp-26(gk3015) 
Fwd Primer (outer): ggtttgtcatgatcggttgg 
Fwd Primer (inner): tcaagtttccctaatccccc 
Rev Primer: ttgaagtcttcattagctccg 
RK151 flp-26(gk3015) 2X backcrossed 
Fwd Primer (outer): ggtttgtcatgatcggttgg 
Fwd Primer (inner): tcaagtttccctaatccccc 
Rev Primer: ttgaagtcttcattagctccg 
VC2012 flp-27(gk3331)  
VC2502 flp-28(gk1075)  
VC2423 flp-33(gk1038)  
RB2269 flp-34(ok3071)  
RB1340 nlp-1(ok1469)  
RB1341 nlp-1(ok1470)  
FX01908 nlp-2(tm1908)  
FX03023 nlp-3(tm3023)  
RB1609 nlp-5(ok1981)  
FX02984 nlp-7(tm2984)  
VC1309 nlp-8(ok1799)  
FX03572 nlp-9(tm3572)  
FX06232 nlp-10(tm6232)  
VC40940 nlp-11(gk891596)  
RB607 nlp-12(ok335) 
Fwd Primer: tttttgcaacacagtcgccg 
Rev Primer (outer): tgatgttcagtacggtctgc 
Rev Primer (inner): tcgattggtggtttggatgg 
RK152 nlp-12(ok335) 2X backcrossed 
Fwd Primer: tttttgcaacacagtcgccg 
Rev Primer (outer): tgatgttcagtacggtctgc 
Rev Primer (inner): tcgattggtggtttggatgg 
VC1108 nlp-14(ok1517)  
VC1063 nlp-15(ok1512) 
Fwd Primer: tttatgccgtgtcttatgtcc 
Rev Primer (outer): gccaggctgtcctattacg 
Rev Primer (inner): tcgtttgacgcacttcttcg 
RK153 nlp-15(ok1512) 2X backcrossed 
Fwd Primer: tttatgccgtgtcttatgtcc 
Rev Primer (outer): gccaggctgtcctattacg 
Rev Primer (inner): tcgtttgacgcacttcttcg 
VC30240 nlp-17(gk960682)  
RB1372 nlp-18(ok1557)  
VC40619 nlp-19(gk951891)  
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RB1396 nlp-20(ok1591)  
FX02569 nlp-21(tm2569)  
FX06351 nlp-22(tm6351)  
FX05531 nlp-23(tm5531)  
FX02105 nlp-24(tm2105)  
VC30122 nlp-25; nlp-26; nlp-42(gk963304)  
VC40271 nlp-27; nlp-28; nlp-29; nlp-30; nlp-31; nlp-34(gk963785)  
FX01931 nlp-29(tm1931)  
VC40420 nlp-32(gk628779)  
FX05434 nlp-35(tm5434)  
FX05156 nlp-36(tm5156) 
Fwd Primer: tgagagacccaccagattgc 
Rev Primer (outer): gggaccaagcttcatgtcga 
Rev Primer (inner): tgttgcttcaagtcgacgga 
RK154 nlp-36(tm5156) 2X backcrossed 
Fwd Primer: tgagagacccaccagattgc 
Rev Primer (outer): gggaccaagcttcatgtcga 
Rev Primer (inner): tgttgcttcaagtcgacgga 
LSC59 nlp-37(tm4393); IstEx24  
FX04393 nlp-37(tm4393)  
FX04780 nlp-37(tm4780)  
VC2357 nlp-38(ok2330)  
FX04085 nlp-40(tm4085) 
Fwd Primer: caagtcgccacatatcccg 
Rev Primer (outer): ccacgcgaccattctcttc 
Rev Primer (inner): gccgctgaaagttgtgttgt 
RK155 nlp-40(tm4085) 2X backcrossed 
Fwd Primer: caagtcgccacatatcccg 
Rev Primer (outer): ccacgcgaccattctcttc 
Rev Primer (inner): gccgctgaaagttgtgttgt 
VC20740 nlp-41(gk963053)  
RK156 
flp-2(ok3351); 
WRM061B_H10; 
pmyo2::mCherry 
 
RK157 
flp-3(ok3265); 
WRM061B_H10; 
pmyo2::mCherry 
 
RK158 
flp-24(gk3109); 
WRM0636B_B10; 
pmyo2::mCherry 
 
RK159 
flp-25(gk1016); 
WRM0627A_A09; 
pmyo2::mCherry 
 
RK160 
flp-26(gk3015); 
WRM0634D_E12; 
pmyo2::mCherry 
 
RK161 nlp-15(ok1512);  
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WRM066C_H12; 
pmyo2::mCherry 
OJ949 
nlp-40(tm4085); vjEx330[Pttx-
3::RFP, nlp-40 genomic 
DNA(~8.8kb)] 
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CHAPTER 4 
 
General Discussion 
 
This body of work highlights the important role of metabolism in two different 
scenarios: (i) in Chapter 2, I use a mouse model to study the contribution of a change in 
metabolism at the organism-level to ALS progression and (ii) in Chapter 3, I use C. 
elegans to study how neuropeptides may contribute to surviving an environmental stress 
(severe oxygen deprivation) during which worms enter a hypometabolic state. Each of 
these projects generated some key insights into disease and stress and raised 
interesting questions for further investigation, some of which I highlight below. 
 
Bridging cellular energy homeostasis and organism-wide metabolic defects in 
ALS 
The findings presented here focus on organism wide metabolic perturbations in 
ALS. However, a key feature of all neurodegenerative diseases is the presence of 
mitochondrial dysfunction in the brain and spinal cord (Lin and Beal, 2006). It remains to 
be understood how nervous system mitochondrial dysfunction at the cellular level and 
organism level metabolic abnormalities are related. Does energy imbalance at the 
cellular level, caused by dysfunctional mitochondria, contribute to organism level 
changes in weight and glucose homeostasis? Alternatively, is organism level metabolic 
dysfunction uncoupled from neuronal mitochondrial damage, and can it be targeted 
independently to alter the course of disease progression?  
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In familial ALS, as well as the G93A SOD1 mouse model used in the studies 
here, mutations in ubiquitously expressed genes such as C9orf72 and SOD1 lead to 
specific degeneration of motor neurons. It is not known why motor neurons are 
selectively vulnerable to damage. Mitochondrial damage is observed in neurons but also 
in non-neuronal tissues, such as liver and skeletal muscle (Nakano and Hirayama, 1987; 
Siklós et al., 1996; Sasaki and Iwata, 2007). There are two potential mechanisms by 
which cellular mitochondrial dysfunction and organism-wide hypermetabolism in ALS 
might be related. (i) Mutant SOD1 leads to peripheral tissue metabolic dysfunction, 
which, in aggregate, results in organism-wide metabolic phenotypes. (ii) The nervous 
system undergoes pathologic changes due to mutant SOD1, and through cell non-
autonomous processes such as hormone signaling, leads to altered metabolism in 
peripheral tissue. In either scenario, the trigger is cellular-level abnormality due to 
mutant SOD1, which causes a cascade of events in both cell autonomous and non-
autonomous ways. The overall, compounded effect of these abnormalities is whole body 
metabolic derangement. In addition to changes in ATP production, features of 
dysfunctional mitochondria in neurodegenerative diseases include generation of reactive 
oxygen species and alterations in the redox status of cells (Lin and Beal, 2006). It is 
possible that aberrant mitochondria influence cellular metabolism through any of these 
different ways. Regardless, these make mitochondrial dysfunction an attractive 
candidate for this trigger. 
Figuring out the mechanistic link between mitochondrial defects at the cellular 
level and organism-wide hypermetabolic profile in ALS will be a key development in 
understanding disease progression. 
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Targeting peripheral tissue for hypometabolism 
 In these studies, MC4R was knocked out in the hypothalamus to induce 
hypometabolism in the G93A SOD1 background. Loss of MC4R, in addition to 
hypometabolism, also induces hyperphagia and increased fat deposits in these mice 
(Balthasar et al., 2005). The increased fat deposition makes mice lethargic and 
sedentary, and complicates interpretation of motor function in the ALS context. We were 
unable to dissociate its effects on feeding from its effects on metabolic rate. Our goal 
was to first generate mice that lacked MC4R globally in the G93A SOD1 background 
(G93A;MC4R-/- ), and then cross them to a Sim1-Cre mouse line to re-express MC4R in 
the paraventricular hypothalamus. As reported in work by Balthasar et al, this partial 
restoration of MC4R was able to reduce obesity in MC4R-/- mice by 60%, while 
maintaining their hypometabolic phenotype (Balthasar et al., 2005). We attempted to 
make this triple mutant cross in our mice, but did not achieve large enough brood sizes 
in both sexes to do the entire range of our experiments. Therefore, we studied the 
double mutant mouse containing a global knockout of MC4R in the G93A SOD1 
background. Our grip strength data suggest that MC4R mutant animals, while obese and 
sedentary, can exert similar if not higher muscle force when compared to WT mice. 
Physiologically, however, it is difficult to tease apart these dual actions of MC4R, and 
practically, drugs targeting MC4R for obesity have met limited success due to a lack of in 
vivo efficacy, side effects and blood brain barrier penetrance (Fani et al., 2014). 
 It may, therefore, be beneficial to target peripheral sources of metabolic rate 
control. One interesting candidate for modulating disease is the gut microbiota, which 
harbor as many as 100 trillion diverse bacteria (Ley et al., 2006). Recently, the 
relationship between the microbiome and the CNS has begun to emerge (Sharon et al., 
2016). For example, mice lacking the gut microbiome (termed germ-free mice) have 
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impaired spatial and object recognition, altered expression of critical neuronal molecules 
such as subunits of the dopamine receptor, as well as the brain derived neurotrophic 
factor (Bercik et al., 2011; Heijtz et al., 2011; Möhle et al., 2016). They also show 
impairments in the blood brain barrier (Braniste et al., 2014). The role of the gut 
microbiota is much less understood in the context of neurodegenerative diseases. One 
study showed that the G93A SOD1 mouse has a presymptomatic increase in intestinal 
permeability and an altered gut microbiome compared to wild type mice (Wu et al., 
2015). The same group did a follow up study and showed that administration of 2% 
butyrate, a by product of bacterial fermentation in the gut, reduced intestinal ‘leakiness’, 
decreased mutant SOD1 aggregation and increased lifespan by an average of 38 days 
in the G93A SOD1 mouse (Zhang et al., 2017). However, there is no report of how the 
altered microbiome of G93A SOD1 mice might alter whole body metabolism. It might be 
worthwhile to do fecal transplantation studies in these mice, where healthy microbiota 
are transplanted into the ALS-like mice, and study changes in metabolism and disease 
progression. 
 In PD, there is a study of fecal transplantation that demonstrated the role the 
microbiome might play in motor dysfunction (Sampson et al., 2016). PD patients have an 
altered gut microbiome compared to healthy controls (Scheperjans et al., 2015). 
Sampson and colleagues showed that the presence of the microbiome led to 
manifestation of motor deficits as well as microglial activation in the caudate/putamen of 
mice overexpressing α-synuclein. This was dependent on short chain fatty acids 
produced by the gut bacteria. Antibiotic administration diminished the microbiome and 
led to improved motor pathology. Strikingly, compared to control mice transplanted with 
fecal microbiomes from healthy human donors, those transplanted with fecal 
microbiomes from PD patients developed significantly altered gut microbiomes of their 
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own. They also developed motor dysfunction compared to the control mice. Together, 
these studies demonstrate the important role of the microbiome in altering disease 
progression, and may act as a peripheral target to manipulate organismal metabolism as 
well. 
 
Neuropeptide signaling and metabolism in C. elegans anoxia 
 Worms have the remarkable ability to survive near-complete oxygen deprivation. 
A hallmark of this phenotype is that worms enter a state of suspended animation where 
they cease most physiological functions including feeding, developing, reproducing and 
locomotion for the duration of the anoxic stress. In this state, they deplete a large 
amount of their carbohydrate reserves and decrease ATP production, indicating a 
hypometabolic phenotype. Our data also shows that aak-2 (AMPK) mutants are 
hypersensitive to this insult, demonstrating a vital role for AMPK in regulating and 
directing appropriate energy consumption to survive the stress. The absence of AMPK 
continued to be fatal to worms in anoxia even in unc-31 mutant worms, which normally 
are anoxia resistant. Work by others shows that loss of AMPK has a similar effect in the 
absence of daf-2, which too is anoxia resistant (Mendenhall et al., 2006a). This indicates 
that functional AMPK is essential to worm survival in anoxia, and acts as a ‘bottleneck’, 
effectively masking the contribution of other pathways such as neuropeptide and insulin 
signaling. Similarly, we confirm here that hyl-2 (ceramide synthase) mutants are 
hypersensitive to anoxia and that this effect too masks that of anoxia tolerance in both 
egl-3 and unc-31 mutants. Ceramides are a class of lipid molecules that are essential for 
proper maintenance of cell membranes. Here, too, hyl-2 loss was detrimental to worm 
survival even in the daf-2 mutant background (Menuz et al., 2009), suggesting a broad 
suppression of anoxia tolerance-promoting pathways. 
96	
	
There is additional data suggesting a critical role for metabolic 
enzymes/transcription factors in anoxia tolerance. A key transcription factor essential for 
glucose metabolism and lipid/fatty acid synthesis is SREBP1. Levels of SBP-1, the worm 
homolog for SREBP1 (sterol regulatory element binding protein), increase with 
increasing duration of anoxia in developing (L3) worms (Taghibiglou et al., 2009b). 
Although the authors used different tools to generate anoxia than us, they found that 5 
hours of anoxia induced lipid accumulation and increased body size in these worms, 
both of which were reversed by knocking down sbp-1. Further, loss of gpd-2 and gpd-3, 
worm homologs of isoforms of the glycolytic enzyme glyceraldehyde-3 phosphate 
dehydrogenase, led to impairments in worm behavior after anoxia, and they act 
downstream of the daf-2/daf-16 pathway (Mendenhall et al., 2006a). Otherwise 
protected daf-2 mutants lost their survival benefit when gpd-2 was also mutated. 
 How are all these genes, essential for various aspects of cellular metabolism, 
coordinating their activity under anoxia? Ceramides negatively regulate transcription of 
SREBP1 in mammalian cells (Worgall et al., 2002). If this is also true in worms, it might 
provide a potential explanation for the mechanism of hyl-2 mutant sensitivity to anoxia. 
Perhaps, in the absence of hyl-2, there is an increase in SREBP1 expression and an 
increase in lipid accumulation that is toxic to worms. Further experiments are needed to 
explore these possibilities and clearly define these relationships with regard to their 
regulation of anoxic stress.  
Understanding how oxygen deprivation alters metabolism and induces metabolic 
changes has important consequences for human health. In an elegant study, it was 
demonstrated that SREBP1 inhibition is protective in an in vitro model of focal ischemia 
(Taghibiglou et al., 2009a). C. elegans is an excellent tool to study genetic and 
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molecular interactions and is ideally suited to study these metabolic gene interactions in 
the context of oxygen deprivation. 
 
Multifactorial response to anoxia in worms 
 Many genes and pathways are implicated in regulating the response to anoxic 
stress in worms, such as daf-2 (insulin signaling), nsy-1 (MAP kinase signaling), rars-1 
(protein translation), skn-1 (oxidative stress response) and hyl-2 (ceramide synthesis). 
To add to this growing list are genes described here – egl-3, unc-31 and egl-21 
(neuropeptide signaling). We tested many of the above genes to see if neuropeptide 
signaling was dependent on their function for its effects in anoxia. We were unable to 
find any interaction, suggesting that most of these pathways acted in parallel to the 
neuropeptide signaling pathway. Hence, multiple pathways can potentially regulate the 
response to this stress in worms.  
 Previous work also suggests that there may be more than one mechanism by 
which neuropeptide signaling mediates survival in anoxia. Anderson and colleagues 
(Anderson et al., 2009) identified that suppressing protein translation (rars-1 loss of 
function) makes worms resistant to extreme oxygen deprivation. This was mediated in 
part by induction of the unfolded protein response pathway, suggesting that other 
mechanisms are also recruited by protein translation to regulate survival after anoxia. 
Similarly, there may be small changes in multiple pathways as a result of disrupted 
neuropeptide signaling, which in sum lead to improved survival in anoxia. 
 This idea is also bolstered by the fact that we were unable to find a strong effect 
of a single neuropeptide in regulating anoxia susceptibility. Based on results from our 
screen, our best candidate is nlp-40, however loss of nlp-40 only provides a partial 
increase in survival compared to N2 worms. This suggests the involvement of additional 
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neuropeptides in egl-3 mediated anoxia tolerance. Further, our RNAi experiments show 
that knocking down egl-3 in multiple neuronal subtypes continues to protect worms from 
anoxia, suggesting that many neuronal subtypes may be involved in this regulation. 
Overall, our data are consistent with the idea that multiple neuropeptides are released 
from multiple neuron-types to make worms sensitive to anoxia. Perhaps small 
downstream effects of these neuropeptides summate and make worms broadly 
vulnerable to anoxic insult. It may be essential to knock down/out egl-3 in many neurons 
to induce an appreciable survival benefit.  
 
Timing of neuropeptide signaling in anoxia 
 An important question that was not addressed in this dissertation is when 
inhibiting neuropeptide signaling is most protective to worms. In other words, when does 
neuropeptide activity make wild type worms sensitive to anoxia? We use genetic 
knockouts or RNAi to diminish neuropeptide signaling via egl-3, unc-31 and egl-21, so 
these worms lack neuropeptide activity throughout their life. Is neuropeptide signaling 
requires before, during or after the anoxic exposure (or some combination of these) to 
sensitize worms to the stress? In future experiments, conditional knockouts or RNAi 
experiments could help to answer this question. Having this information may give us 
clues about the role of neuropeptides in modulating this phenotype, and more 
appropriately target therapeutic interventions if this were to be translational. 
 Another important observation in our work, which confirms observations by 
others, is that there is a developmental regulation of worm susceptibility to anoxia (Van 
Voorhies and Ward, 2000; Padilla et al., 2002). In our assay, L4 staged developing 
worms were sensitive to 48h of anoxia, while young adults were resistant. The major 
physiological events between these two stages of worm development are vulval 
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development, a period of lethargus and the final molt/cuticle development (Raizen et al., 
2008; Schindler et al., 2014; Mok et al., 2015). Studying mutants in these pathways may 
clarify if disruption of these events contributes to the sensitivity of worms to anoxia 
during L4. 
 
Protein translation, neuropepitde synthesis and anoxia 
 As mentioned earlier, Anderson et al showed that mutating aminoacyl-tRNA 
synthetases had a strong positive effect on worm survival in anoxia (Anderson et al., 
2009). This suggests that decreasing protein translation is beneficial in worms. From an 
energetic perspective, observation is consistent with preserving ATP loads during anoxia 
and redirecting cell biology away from energy-expensive catabolic processes like protein 
translation (one of the primary roles of AMPK). In their study, the authors found that the 
effect of reducing protein translation was protective partially due to upregulation of the 
unfolded protein response (UPR) machinery.  
One idea that we did not explore in our work, is if there is decreased 
neuropeptide translation and decreased neuropeptide signaling in the aminoacyl-tRNA 
synthetase mutants such as rars-1. In other words, if we tested double mutants bearing 
a loss of function in egl-3/unc-31 as well as rars-1, would there be an additive survival 
benefit in anoxia, or would the double mutant be similar to either individual mutant? If 
there is no additive effect of the two mutations, they likely occur in the same genetic 
pathway, suggesting that a rars-1 mutation may act to increase anoxia survival by 
decreasing neuropeptide signaling. 
Additionally, is the UPR induced in neuropeptide signaling-deficient worms? We 
show that egl-3 and unc-31 mutant worms are sensitive to tunicamycin (a UPR inducer) 
and have reduced lifespan when raised on tunicamycin. This is a preliminary indicator 
100	
	
that neuropeptide mutant worms are not resistant to sustained tunicamycin-induced 
toxicity, but it is not known if the UPR is induced in unc-31 and egl-3 mutant worms at 
baseline or after anoxia. If neuropeptide signaling does not rely on the UPR for its effects 
on anoxia, it may help to partially explain the protection conferred by rars-1 deletion. 
 
Data variability 
 On a technical note, one of the major challenges in the anoxia experiments was 
the significant amount of biological variability in the data. N2 survival ranged from 10-
80% and unc-31 survival varied from 20-95% over 40-50 independent experiments of 
48h anoxia in L4 worms. This made some data difficult to interpret, affected the results 
of our neuropeptide screen and necessitated many independent experiments to reliably 
conclude a biological effect. By and large, there was very little variation between the 3 
technical replicates within an experiment, but the variability was substantial between 
different experiments. We tried to address the source of this variability by accurately 
staging animals at the same stage of L4 and positioning plates differently in the bags, 
but we were unable to find a systematic factor that affected the range of survival. 
However, there are some additional factors that may contribute to the variability that we 
did not explore. Some of these are: precise volume of agar in plates, gentleness of 
handling worms while placing them on plates, lot-to-lot variability in culture reagents, 
small changes in the incubator environment and age of food on the plate. 
 We know that preconditioning worms to a stressor like a different diet, a different 
growth temperature, or a short bout of anoxia enhances their survival under long term 
anoxia (Dasgupta et al., 2007; LaRue and Padilla, 2011). Could it be that the source of 
the variability comes from previous experience? Factors such as plate crowding, freshly 
seeded food plates (‘younger’ OP50 vs ‘older’ OP50) and contamination in an earlier 
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generation are some factors that can be readily controlled for in a systematic way. 
Minimizing variability will be a huge benefit to ease of conducting and interpreting future 
experiments. 
 
Conclusion 
 A central theme bridging these two projects is that cell autonomous and non-
autonomous factors regulate how an organism responds environmental stress and 
disease. In the case of ALS, we demonstrate that decreasing metabolic rate by loss of 
MC4R in the hypothalamus does not alter progression or outcome of ALS. However, we 
do not know if there are cellular level changes to mitochondrial health, and if this is 
different in the nervous system compared to muscles. In fALS, a mutation in a single 
gene in all cells in the body affects mitochondrial health in many cells, whole body 
metabolism but preferentially causes death of motor neurons. This points to cell 
autonomous cellular damage. However, it remains to be determined what the source of 
metabolic derangement in ALS is and how it relates to preferential death of motor 
neurons. As suggested earlier, one potential mechanism is that a cell non-autonomous 
factor, potentially released by energy starved neurons, signals to the rest of the body 
and causes whole body hypermetabolism. 
 In the case of anoxic stress, we establish that loss of neuropeptide signaling is 
beneficial to worms undergoing anoxia in a manner that is independent of many 
established stress-resistance pathways. There is likely a group of neuropeptides, of 
which nlp-40 is one, that regulates this response, and the neuropeptides are secreted 
from the nervous system. This work demonstrates that soluble factors such as 
neuropeptides can act cell non-autonomously to regulate organism level response to an 
external stress.  
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 This work sheds light on the bidirectional role of metabolism in disease and 
stress. Changes in metabolic rate can be an adaptive response to external stress, and 
can be modulated to impact disease in sophisticated and specific ways. 
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Lifespan of neuropeptide signaling mutants 
 In Chapter 3, the readout for all our experiments was survival of worms 24h after 
recover from a 48h anoxic insult. However, this did not tell us anything about the biology 
of the worms after this 24h post-anoxia window. We were curious to see if the various 
neuropeptide signaling mutants we used in Chapter 3 had any differences in lifespan 
pre- and post- anoxia. We placed L4 worms on plates supplemented with 5-Fluoro-2′-
deoxyuridine (FUdR) at a final concentration of 200uM, and measured their survival on 
these plates either at baseline, or that of surviving worms after 48h of anoxia.  FUdR is a 
potent inhibitor of DNA synthesis, and was used here to prevent eggs laid by test 
animals from hatching. In this manner, we avoided ‘contamination’ by progeny and 
limited repeated handling and moving the test worms.  
We found that all the neuropeptide mutants – egl-3 (ok979), egl-3 (gk238), egl-21 
(n476), unc-31 (e928) – were significantly longer lived than the wild type line (Fig A1a). 
Additionally, we measured the lifespan of surviving worms after the 48h anoxic insult, 
and found that they continued to be longer-lived post anoxia (Fig. A1b). Interestingly the 
lifespan of all lines, including N2, was higher post anoxia than that at baseline. Hence, 
L4 staged neuropeptide mutant worms have significantly greater survival compared to 
N2 after 48h anoxia (see Chapter 3), and the worms that survive anoxia have a greater 
lifespan compared to N2 worms. Additionally, anoxia may act as a stressor that allows 
worms that can survive the stress to have increased lifespan than those that do not 
experience this stress. 
105	
	
 
 
‘Healthspan’ of neuropeptide signaling mutants 
 The lifespan of different worm lines tells us about how long they live, but does not 
tell us about how well they live. We attempted to get a measure of worm ‘health’ post 
anoxia. To do this, we scored anoxia-surviving worms 6 days after they were removed 
from the anoxic biobags. We looked to see if worms had developed to adulthood, had 
sexually matured and had normal locomotion on the plates. If they did, we scored these 
as ‘healthy’. The worms that did not achieve these benchmarks were scored as 
‘unhealthy’. These ‘unhealthy’ worms generally had one or more of the following 
phenotypes, that did not change throughout their life: (i) they were much smaller than 
normal adult worms, (ii) they had aberrant locomotion and stayed in the same spot on 
the plate, (iii) they did not bear eggs, (iv) they appeared very pale, seemingly lacking the 
characteristic dark color of adult worms due to fat deposits, (v) they had a ‘sheath’ 
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Fig. A1. Survival of anoxia tolerant neuropeptide mutants. Lifespan of mutants in egl-3, egl-21 
and unc-31 are plotted against N2 lifespan a) at baseline and b) after 48h anoxia. Data are 
analyzed using the Mantel-Cox test for survival curve comparisons. *p < 0.05, ***p < 0.001, ****p < 
0.0001
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surrounding the entire body, presumably the cuticle that they were unable to shed during 
molting. 
 If the worms met any of these phenotypic criteria, we scored them as ‘unhealthy’. 
Images of smaller, paler worms without eggs alongside ‘healthy’ worms are presented in 
Fig. 2a-e. We also noticed that these worms tended to have shorter lifespan compared 
to the ‘healthy’ worms on the same plate. These ‘unhealthy’ animals were present in all 
the strains, including N2. However, there were strikingly fewer ‘unhealthy’ N2 worms 
post-anoxia than all the other strains (Fig. A2f). This indicates that although a smaller 
fraction of N2 worms survive the initial anoxic insult, those that do have a ‘healthier’ 
lifespan. Conversely, a higher proportion of neuropeptide signaling mutant worms 
survive the initial anoxic insult, but many of them are ‘unhealthy’ after anoxia. 
Additionally, the lifespan data in Fig A1b contains neuropeptide signaling mutants that 
are both ‘healthy’ and ‘unhealthy’. This suggests that the anoxic insult generates two 
populations of worms in these mutants, ones that are shorter-lived and sicker, and ones 
that are very long-lived and healthier.
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Fig. A2. ‘Healthspan’ of anoxia-tolerant neuropeptide signaling mutants after 
anoxia. a-e) Representative pictures of ‘healthy’ and ‘unhealthy’ surviving worms in N2 
and anoxia-tolerant neuropeptide signaling mutants 6 days after 48h anoxia. f) 
Quantification of percent ‘unhellthy’ worms in every genotype, alongside total number of 
worms.
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Survival of egl-3 and unc-31 mutants after anoxia is additive  
 Since egl-3 is required for neuropeptide maturation and unc-31 is required for 
neuropeptide secretion, we hypothesized that they are in the same genetic pathway, 
where egl-3 acts upstream of unc-31. Compared to wild type worms, loss of function 
mutants in each of these genes leads to increased survival after 48h anoxia in L4 worms 
(Chapter 3). If they are in the same pathway, survival of egl-3;unc-31 double mutants 
should not be any higher than either of the single mutants. On the other hand, if they 
were in unrelated, parallel pathways, the combined survival of the double mutant would 
be the sum of their individual survival phenotypes. In order to test this hypothesis, we 
generated the double mutants and tested their survival after 54h anoxia. We chose a 
higher anoxia duration because there was a ceiling effect of survival in these mutants at 
48h, making it difficult to ascertain if they were truly in the same or parallel pathways. 
To our surprise, we found that egl-3;unc-31 double mutants had significantly 
greater survival compared to either of the single mutants (Fig. A3). This suggests that 
egl-3 and unc-31 may act via different mechanisms, or in different cells, to confer a 
survival benefit under anoxia. However, this requires further study. Further, it is worth 
noting that survival of egl-3 and unc-31 mutants is much lower at 54h (30-40%) than at 
48h (70-90%), and is not significantly different from N2. This suggests that there is a 
limited window of anoxic exposure where loss of egl-3 and unc-31 activity is protective in 
worms. 
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Fig. A3. Survival of egl-3;unc-31 double mutants after anoxia. Worms were exposed to 
54h anoxia, and allowed to recover for 24h before scoring live/dead worms (n = 4 
independent experiments). Data were analyzed by one-way ANOVA with Tukey’s test for 
multiple comparisons. ***p < 0.001.
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